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“Seek simplicity and distrust it” 
 
 
Alfred North Whitehead (1861-1947) 
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Summary 
Background: Colorectal cancer (CRC) can be considered a disease of the elderly, with a 
median age of diagnosis of 72 years. Surgery is the main treatment for colorectal cancer. As 
chronological age does not accurately reflect physiological reserves in the heterogeneous 
elderly population, it has been suggested that older cancer patients may benefit from a 
comprehensive geriatric assessment (CGA) before treatment decisions are made. A CGA is a 
systematic approach aiming to assess physical function, comorbidity, polypharmacy, 
nutritional status, cognitive function, and emotional status in older patients. Based on a CGA, 
patients may be divided into three groups: Fit, intermediate, or frail. Few prospective studies 
have investigated the associations between elements of a CGA and surgical outcomes in 
elderly patients. Furthermore, the definition of  “frailty” derived from a CGA is controversial. 
In geriatric medicine, frailty is more commonly defined as a cluster of physical impairments 
(often called the physical phenotype of frailty – PF).  
 
Aims: To study the association between a categorization of patients into the groups fit, 
intermediate, or frail based on a pre-operative CGA and the risk of post-operative 
complications in elderly CRC patients who were electively operated; to identify independent 
predictors of post-operative complications and survival from a CGA and Eastern Cooperative 
Oncology Group performance status (ECOG PS); to compare a pre-operative multi-domain 
frailty measurement based on a CGA to a modified version of PF in older CRC patients, and 
to analyze the ability of the two measurements to predict post-operative complications and 
overall survival; to compare levels of inflammatory biomarkers (CRP, IL-6, TNF-α), and D-
dimer in older CRC patients classified according to the two frailty definitions. 
 
Methods: Patients ≥ 70 years electively operated for all stages of CRC from 2006 to 2008 in 
three Norwegian hospitals (Ullevaal University Hospital, Aker University Hospital, and 
Akershus University Hospital) were consecutively included. A pre-operative CGA, an 
assessment of self-reported health, measurements of grip strength and gait speed were 
performed, and blood samples were drawn within 14 days of surgery. CGA-frailty was 
defined as fulfilling one or more of the following criteria: Dependency in personal activities 
of daily living, severe comorbidity, cognitive dysfunction, depression, malnutrition, or >7 
daily medications. PF was defined as the presence of three or more of the following criteria: 
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Unintentional weight loss, exhaustion, low physical activity, impaired grip strength, and slow 
gait speed. Outcome measures were post-operative complications (any complication and 
severe complications) and overall survival. 
 
Results: Patients (182) with a median age of 80 years (range, 70-94 years) were included. For 
the categorization into the three CGA-groups, 178 patients were available for analyses, while 
176 patients were available for the comparison between the two frailty classifications. 
Twenty-one patients (12%) patients were categorized as fit, 81 (46%) as intermediate, and 76 
(43%) as frail. Eighty-three patients experienced severe complications, including three deaths; 
7/21 (33%) of fit patients, 29/81 (36%) of intermediate patients, and 47/76 (62%) of frail 
patients (p=0.002). Increasing age and ASA class were not associated with complications. 
Severe comorbidity was an independent predictor of severe complications (odds ratio [OR] 
5.62; 95% CI 2.18 to 14.50) and early mortality (hazard ratio [HR] 2.78; 95% CI 1.50 to 
5.17). Dependency in instrumental activities of daily living (IADL) and depression were 
predictors of any complication (OR 4.02; 95% CI 1.24 to 13.09 and OR 3.68; 95% CI 0.96 to 
14.08, respectively) while impaired nutrition predicted early mortality (HR 2.39, 95% CI 1.24 
to 4.61). When added to the models, ECOG PS independently predicted both morbidity and 
early mortality, and ECOG PS was a more powerful predictor than IADL-dependency, 
depression, and impaired nutrition. The agreement between the two frailty classifications was 
poor. CGA-frailty was identified in 75 (43%) patients, while PF was identified in 22 (13%) 
patients. Only CGA-frailty predicted post-operative complications (p= 0.001). Both CGA-
frailty and PF predicted survival. Levels of CRP and IL-6 were significantly higher in frail 
compared with non-frail patients within both measures. 
 
Conclusions: CGA can identify frail patients who have a significantly increased risk of 
developing post-operative complications after elective surgery for CRC. This multi-domain 
frailty measurement appears to be more useful than frailty identified from a modified version 
of the physical phenotype of frailty criteria in predicting morbidity, but for long-term 
outcomes such as overall survival, both measurements are predictive. Severe comorbidity, 
IADL-dependency, depression, and impaired nutrition seem to be the most important CGA-
elements predictive of post-operative complications and overall survival. As ECOG PS 
predicts all outcomes, a consistent use of ECOG PS in studies of cancer surgery is 
recommended.  
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Overture 
Colorectal cancer mainly affects elderly patients; in Norway sixty percent of patients are more 
than 70 years old at diagnosis1. The resection rate is high even in advanced age for this cancer 
type, leading to a large number of elderly patients undergoing surgery2. Many studies have 
attempted to link pre-surgical risk factors to post-operative morbidity, but most of these lack 
information about common risk factors among elderly patients, such as functional status, 
malnutrition, depression, and dementia. Several review articles have advocated the routine use 
of a comprehensive geriatric assessment (CGA) in elderly cancer patients in order to shape 
interventions and clinical decisions in oncology3-6.  A CGA offers a systematic approach 
aiming to assess physical functioning, comorbidity, polypharmacy, nutritional status, 
cognition, and emotional status in elderly patients. Due to a lack of clinical studies, it still 
remains unclear whether the additional information obtained from a CGA adds to a routinely 
performed pre-operative workup in terms of predicting treatment complications and survival 
in elderly patients operated for colorectal cancer.  
 
Thus, the aim of this prospective observational cohort study was to examine the relationship 
between a pre-operative CGA performed in 187 patients aged 70 years and older and two 
post-operative outcomes: complications within 30 days of surgery and overall survival. We 
primarily wanted to study an overall categorization into three patient groups (fit, intermediate, 
or frail) based on the complete CGA. Subsequently we wanted to study which domains of the 
CGA were the most important predictors of the outcomes.  
 
The term frailty is often used to describe an elderly patient who is at high risk for adverse 
outcomes such as hospitalization and mortality. It is widely debated within the geriatric 
literature how to identify such a patient. Particular interest is taken in patients who appear 
healthy, but have limited reserve capacity and therefore decompensate when they are exposed 
to stress such as surgery or an infection. As our cohort may be viewed as a group of patients 
who are exposed to a similar form a stress, a surgical resection of a colon or rectal tumor, we 
also used our dataset to test the ability of two commonly used frailty-classifications to predict 
post-operative complications and overall survival. 
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Based on our dataset and analyses, we believe that we have contributed to the scientific 
rationale for recommending CGA in elderly cancer patients. This may impact the 
development of geriatric oncology as a scientific discipline. Surgeons and oncologists treat a 
large number of elderly patients, but few programs offer specialized training in geriatric 
surgery or geriatric oncology. By showing that typical geriatric elements, such as functional 
status, comorbidity, and depression, were more important predictors of surgical outcomes 
than increasing age and American Society of Anesthesiologists Physical Status Classification, 
we hope to increase the interest among surgeons to assess such factors in clinical practice and 
to include them in scientific publications. For geriatricians, we believe that our data regarding 
the clinical usefulness of two different ways of identifying frailty represent a valuable 
contribution to the frailty debate. 
 
There are several aspects of surgery in elderly patients with colorectal cancer that will not be 
discussed in this dissertation. As we have merely concentrated on the pre-operative 
assessment of the elderly surgical patient, important factors such as pre-operative preparation 
of the patient for surgery, type of anesthesia, the surgical procedure itself, or implementation 
of specific post-operative measures have not been covered. Even though survival analyses are 
included in the publications from our study, we have not yet looked into quality of life after 
surgery, long-term functional consequences of the surgical treatment, or causes of deaths in 
our cohort. However, data regarding these long-term aspects have been collected, and will be 
published on a later occasion. 
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Introduction 
The prevalence of cancer rises with increasing age. In Norway, 60% of colorectal cancers 
occur after the age of 701. When treating cancer in older adults, a number of challenges have 
to be faced. Firstly, there is little evidence from the medical literature regarding this group of 
patients7,8. Patients are often excluded from clinical trials due to advanced age and severe 
comorbidity. Secondly, the elderly population is characterized by a marked variability in the 
rate of aging, and chronological age does not accurately reflect remaining life expectancy and 
treatment tolerance9. Thirdly, the training of oncologists and surgeons may in some settings 
focus on choosing the best therapy for physically fit patients. Geriatricians, on the other hand, 
have limited knowledge about oncology and surgery.  
 
Over the recent years there has been a growing interest in a subspecialty field of oncology; 
geriatric oncology. One of the major priorities within this field is to develop an assessment 
tool for oncologists and surgeons who treat elderly cancer patients5,10,11. This tool should be 
able to capture an older individual’s “biological age”, independently of his or her 
chronological age. The perfect assessment tool would identify crucial factors such as 
remaining life expectancy and treatment tolerance, as well as remediable problems that might 
influence treatment choices, therapeutic adherence, discharge planning, and rehabilitation. 
 
Cancer and aging 
Increasing age is the single most important risk factor for cancer development12. However, the 
age-dependent escalation in cancer risk is mostly due to a marked increase in epithelial 
carcinomas from 40 to 80 years of age. After 80 years, the incidence of cancers level off. A 
common mechanism for aging and cancer development is the generation and accumulation of 
cellular damage. Interestingly, other divergent mechanisms that have opposing effects on 
cancer and aging are also identified, and these mechanisms seem to protect us from cancer but 
promote aging. Examples are telomere shortening and cellular senescence. These mechanisms 
prevent excessive cellular proliferation, thereby limiting long-term regeneration and 
longevity. To date, most of the fundamental questions regarding the relationship between 
cancer and aging remain unanswered13. 
 
18 
 
Biological age and frailty 
As almost all age-related changes lead to reduced function, aging itself increases vulnerability 
for adverse health events14. However, the elderly population is characterized by a marked 
variability in the rate of functional deterioration, both between individuals and within 
individuals. Thus, as the passage of time is only indirectly related to age, knowing a patient’s 
chronological age is not sufficient to determine the individual’s functional or physiological 
capacity14. Instead one speaks of biological age as an indicator of the rate of aging in an 
individual human. Various biomarkers have been proposed to determine biological age in 
humans, and some examples are lung capacity, grip strength, and systolic blood pressure. The 
concept of reserve capacity is frequently discussed in the context of biological age. In order to 
determine susceptibility in an individual human it may be relevant to understand the 
compensatory mechanisms that let older individuals maintain their autonomy in daily life 
despite deteriorations in organ functions15. For example, a patient may have balance problems 
due to central nervous system disease. Such a patient potentially needs more muscle strength 
than is normally needed in order to maintain normal walking to compensate for the balance 
problems – good strength compensates for the impaired balance16. But because the patient is 
already using his or her reserve capacity, there is an increased risk of decompensation (in this 
case falling) if further stress is experienced, for example if the patient slips on a wet surface 
while walking. The analogue in the context of elderly patients undergoing surgery for 
colorectal cancer would be an individual that appears relatively healthy, but is using all his 
compensatory mechanisms to preserve the autonomy in daily life. When facing a challenging 
situation such as surgery, the limited reserves may manifest themselves as post-operative 
complications and prolonged recovery.   
 
In geriatric medicine, physicians often deal with susceptible patients who are at risk for 
imminent decline in physical and cognitive functioning. A term that is frequently used to 
describe such patients is frailty. Interestingly, a consensus definition of frailty is still lacking, 
even after a 2007 meeting of a task force on frailty including experts from Europe, Canada, 
and the US17. However, frailty in an individual is widely recognized as “an elderly patient 
who is at heightened vulnerability to adverse health status change because of a multisystem 
reduction in reserve capacity”18. This corresponds to a high biological age. Because of the 
increased risk of adverse outcomes, a frail patient is likely to be a candidate for preventive 
interventions. The increased susceptibility may lead to fluctuations in health status and 
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require intensive medical treatment in case of an acute medical situation. Furthermore, a frail 
patient has an increased risk of complications, toxicity, and side effects of medical 
interventions. Thus, special attention is needed when treating such a patient with surgery, 
chemotherapy, or other drugs. It also remains controversial how to identify frailty in an 
individual, as will be discussed below. 
 
Assessment of elderly cancer patients 
Comprehensive Geriatric Assessment (CGA) 
The heterogeneity of the aging process has practical consequences for the assessment of 
elderly cancer patients: patients need individualized assessments to approximately determine 
their biological age. There is no simple way to assess biological age, but an approach 
frequently used by geriatricians involves a comprehensive geriatric assessment. Although no 
standardized version of CGA exists, there is general agreement within the literature of the 
components that comprise a CGA. Areas where older adults often present with problems are 
systematically assessed. The general composition of a CGA involves functional status, 
comorbidity, polypharmacy, nutritional status, emotional status, cognitive function and social 
support.  
 
Functional status is often divided into primary (or personal) activities of daily living (PADL) 
and instrumental activities of daily living (IADL). PADL-functions are often abbreviated just 
ADL and constitute basic self-care abilities such as feeding, transferring from bed to chair and 
bathing/showering. Requiring assistance in ADL, or ADL-dependency, implies that a person 
needs help from a caregiver on a daily basis in order to survive. IADL describes more 
advanced activities, such as doing laundry, managing money and driving, and provides an 
estimate of the person’s ability to live an independent life. Requiring assistance with ADLs or 
IADLs is associated with an increased risk of further functional decline19, hospitalization19, 
and mortality19-21. Functional status is not a stable variable, and declines in physical functions 
that persist over time are associated with poorer overall survival and increased risk of 
hospitalizations compared with transient declines in physical function22. This highlights the 
need for repeated measurements of functional status. In the context of a planned surgical 
procedure, knowledge of the functional status prior to the operation provides a useful 
benchmark for planning post-operative rehabilitation. 
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Comorbidity is defined as the presence of one or more disorders in addition to the index 
disease (in this context cancer is the index disease). Comorbidity may impact on a patient’s 
risk of mortality and morbidity, as well as tolerance to cancer therapy. A comorbidity 
assessment is therefore necessary to answer the following questions: Is the patient’s 
remaining life-expectancy more likely to be limited by the cancer or another comorbid 
medical condition23? Will the comorbid condition(s) affect treatment tolerance? What are the 
interactions between the comorbid medical conditions and the cancer disease? In general, the 
severity of comorbidity is associated with survival in cancer patients, independent of cancer 
stage24. Not surprisingly, it has also been shown that the prognostic importance of overall 
comorbidity depends on the mortality burden of the index cancer: comorbidities seem to have 
the greatest prognostic impact among groups with the highest survival rate, and least impact 
in groups with the lowest survival rate25. If tumor complications are unlikely to occur during 
the patient’s remaining lifetime, cancer treatment may do more harm than good. Drugs that 
are used in the oncology population, such as steroids, may unmask or exacerbate comorbid 
illnesses, such as diabetes or glucose intolerance. Furthermore, specific chemotherapeutic 
drugs may be contraindicated or must be used with caution due to comorbidity. Examples are 
neurotoxic drugs that may exacerbate underlying neuropathy, or the increased risk of 
trastuzumab- or anthracycline-associated cardiomyopathy in the presence of hypertension26. 
In order to study comorbidity statistically, a comorbidity index is useful. Examples of 
comorbidity indexes used in geriatric oncology are the Charlson’s comorbidity index and the 
Cumulative Illness Rating Scale27.  
 
Nutritional status is part of a CGA because nutritional problems are frequent in elderly 
patients, and weight loss of 4-5% is associated with an increased risk of mortality28,29. The 
prevalence of malnutrition varies depending on which assessment tool is utilized, and differs 
between populations. In two studies from Norway, 39% of surgical patients were either 
moderately or severely malnourished30, and about 70% of patients older than 70 years 
admitted to the medical department were at risk for malnutrition31. Weight loss and 
malnutrition have been reported as risk factors for post-operative complications in patients 
with gastrointestinal cancer32,33. Furthermore, weight loss prior to diagnosis or treatment of 
gastrointestinal cancer has been associated with poor outcomes, including an association 
between weight loss and poorer quality of life34. 
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The risk of depression increases with increasing age. The prevalence of depression in patients 
older than 60 years was reported to be 19% in a Norwegian study35. Self-reported depression 
in patients over the age of 80 years was 20% in another population-based Norwegian study36. 
In older age, depression is associated with functional decline, increased need for informal 
caregiving, and increased use of health care resources37-39. It is possible that patients with 
cancer are at an increased risk for depression, given the life-threatening nature of the 
diagnosis, related symptomatology, and the need for aggressive treatment. Furthermore, 
depression may interfere with the motivation to receive treatment for cancer. It has to our 
knowledge not yet been established how to optimally deal with depression in elderly patients 
in the context of a cancer diagnosis and the subsequent treatment such as surgery and 
chemotherapy.  
 
The prevalence of cognitive impairment and dementia increases with age. Cognitive 
impairment is associated with an increased risk for functional decline and an increased risk of 
mortality40-42. In cancer patients, cognitive performance may be affected by fatigue, 
symptoms, depression, and pain. Cognitive problems are frequently not recognized, and 
formal testing may be required. The presence of cognitive impairment may lead to a delay in 
the diagnosis of cancer, as well as affect the delivery of care. In a study of older patients with 
colon cancer and dementia, Gupta and colleagues found that patients with dementia were 
twice as likely to have colon cancer reported after death (the data were derived from autopsy 
or the death certificate)43. When cancer was diagnosed while the patients were alive, it was 
found that patients with dementia were less likely to obtain a pathological diagnosis and 
undergo surgical resection. Whether cancer and/or cancer treatment impacts on cognitive 
function in cancer survivors is not clear. In one study of patients aged 55 years and older who 
had survived cancer for four or more years, no difference in self-reported cognitive function 
was found44. Another prospective longitudinal study that included comprehensive 
neuropsychological assessment of cognitive function also failed to find increased risk of 
developing dementia in patients with a history of cancer compared with cancer-free 
participants45. Conflicting results were found in a study of twins aged 65 years and older from 
the Swedish twin registry46. This study identified twin pairs where one twin was a cancer 
survivor, while the other had no history of cancer. The cancer survivor twin was more likely 
to have cognitive dysfunction than the unaffected twin. Cognitive function was measured by a 
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telephone mental screening interview or informant report in this study. In conclusion, the 
association between cancer and development of cognitive dysfunction is complex and 
depends on a variety of factors such as treatment modalities (surgery, radiation therapy, 
medical anticancer therapy), type and combination of cancer drugs, comorbidities, and diet. 
Nevertheless, an assessment of cognitive function is needed prior to prescription of cancer 
therapy in order to ensure that the patient can provide informed consent and understands the 
risks, benefits, and alternatives of the therapy. It is also vital to know whether the patient 
realizes the side effects of therapy, and when to seek help. Another question is whether the 
patient is able to comply with the drug regimen, or if additional care is needed. In the surgical 
setting, pre-operative cognitive impairment is associated with an increased risk of post-
operative delirium, which may be prevented47.  
 
Loneliness and social isolation are associated with increased mortality and morbidity in the 
elderly48,49. It has been shown that the presence of social support impacts the treatment 
received for cancer. In a study of patients with stage III colon cancer from 2009, it was found 
that divorced/widowed marital status was associated with lower chemotherapy use50. 
Assessment of social support is also vital for treatment planning. 
 
In clinical geriatrics, the CGA is frequently carried out in the presence of a multidisciplinary 
team. The team usually includes some or all of the following specialists: a geriatrician, a 
geriatric nurse, a physiotherapist, an occupational therapist, a dietician, a social worker, and a 
pharmacist. The CGA-assessment may be carried out with or without the use of standardized 
tools for the various domains. In the Department of Geriatric Medicine at Oslo University 
Hospital, for example, ADL-functions are usually scored, while comorbidities are recorded 
from the routinely performed clinical examination without the use of a formal scoring tool. 
Nutritional status beyond body mass index and depression are not systematically assessed. 
The use of standardized tools in clinical practice seems to be more established in oncology 
departments, and oncologists often ask for a copy of “the CGA” scoring sheet, which does not 
exist.  
 
Categorization into groups fit, intermediate, and frail based on CGA 
One of the first authors to suggest the use of CGA in older adults with cancer was oncologist 
and geriatrician Lodovico Balducci at Moffitt Cancer Center & Research Institute in Florida, 
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USA. Balducci outlined three treatment groups of elderly cancer patients that could be 
identified from the CGA – fit elderly, intermediate elderly, and frail elderly. He suggested 
that the fit elderly should receive treatment similar to younger patients, while frail elderly 
should be offered palliative care. The intermediate patients would need an individualized 
approach51. Balducci’s criteria for defining the frail elderly were based on the criteria 
originally presented by Winograd in 199152. The Winograd criteria were: impairment of 
single ADL, imbalance/dizziness, impaired mobility, chronic disability, weight loss, falls 
during last three months, confusion, vision or hearing impairment, depression, malnutrition, 
mild or moderate dementia, urinary incontinence, social or family problems, polypharmacy, 
and prolonged bed rest. In several review articles about the use of CGA in geriatric oncology, 
a categorization of patients into the three fitness groups (fit, intermediate, and frail) has been 
advocated53-55, and intuitively this method seems reasonable. Unfortunately, research data 
supporting this approach in elderly cancer patients are scarce. Furthermore, as mentioned 
above, the expression “frailty” is heavily debated, and there is still no clear and universally 
accepted definition of this term17.  Nevertheless, the Balducci criteria for defining frailty are 
frequently cited in the context of geriatric oncology. 
 
The physical phenotype of frailty criteria 
Within the geriatric and biogerontological literature, a definition of frailty as an entity 
separate from comorbidity and disability, as suggested by Fried and colleagues, is more 
commonly used than the multi-dimensional Balducci definition, especially in the US56. This 
physical phenotype of frailty is identified when fulfilling at least three of the following five 
criteria: unintentional weight loss, exhaustion, slow walking speed, low physical activity, and 
weakness. Clusters of physical impairments form the basis of frailty within this construct. The 
physical phenotype of frailty has been validated in several population-based studies as 
identifying those at high risk for disability, falls, hospitalizations, hip fracture, and mortality57-
60. The physical frailty phenotype has rarely been discussed in geriatric oncology publications 
or during the annual geriatric oncology meetings organized by the International Society for 
Geriatric Oncology (personal experience). When our study was initiated, there were to our 
knowledge no studies that had investigated whether the physical phenotype of frailty was able 
to predict short-term outcomes, such as post-operative complications after elective surgery, in 
a homogeneous cohort of elderly cancer patients. 
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Laboratory biomarkers of frailty 
Interesting data have shown associations between various biomarkers in blood in elderly 
people and negative outcomes such as mortality, disability, and frailty. The term 
“inflammaging” is frequently used to describe physiological and molecular changes consistent 
with the aging process that are associated with chronic activation of inflammatory pathways. 
In a population-based study by Cohen and colleagues, markers of inflammation (interleukin-6 
– IL 6) and coagulation (D-dimer) were associated with mortality and functional decline61. In 
another prospective longitudinal study of healthy non-disabled older adults, higher levels of 
C-reactive protein (CRP) and IL-6 were associated with an increased risk of death62. An 
association between higher plasma levels of tumor necrosis factor-α (TNF-ɑ) and death in 
community-dwelling subjects aged 72-92 years and in centenarians has also been found63,64. 
Chronic exposure to inflammatory mediators may lead to the alterations in multiple 
physiological systems associated with the physical frailty phenotype in the elderly65,66. 
Hubbard and colleagues have shown that inflammatory activity is higher in frail than in non-
frail patients across different frailty measures67, and higher levels of CRP were associated 
with the physical phenotype of frailty in 4735 community-dwelling adults aged 65 years and 
older that were participating in the Cardiovascular Health Study66. The association between 
biomarkers and frailty do not provide insight regarding causality, but biomarkers may add to 
the validity of the clinical diagnosis of frailty. Furthermore, if measurements of individual 
inflammatory biomarkers become easier and cheaper, and more specificity is assigned to the 
markers, perhaps serum inflammatory markers may turn out to be useful clinical tools that can 
help identify vulnerability in elderly patients and guide therapeutic interventions. The 
importance of elevated levels of biomarkers such as CRP, IL-6, and D-dimer has also been 
described in the oncology literature. Inflammation is linked to cancer in some way, and 
possible mechanisms include the production of reactive oxygen species in chronic 
inflammation. Such reactive oxygen species may cause DNA damage, activation of growth 
factors, and inhibition of apoptosis68. In a study of patients with advanced non-small-cell lung 
cancer, higher IL-6 levels were associated with poorer overall survival and poorer 
performance status69. Baseline D-dimer levels have been found to predict overall survival and 
disease progression among patients with metastatic colon cancer70. In the surgical literature, 
IL-6 has gained some attention because IL-6 levels seem to be associated with the degree of 
operative stress, and cytokine production may play a role in post-trauma events71. In our 
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study, we collected blood samples pre-operatively in order to study the association between 
biomarkers and the two measurements of frailty and between biomarkers of inflammation and 
the occurrence of post-operative complications.  
 
Previous research on CGA and frailty in clinical 
geriatric oncology 
Even though a large number of review articles recommend CGA in elderly cancer patients 5,72-
77, dedicated clinical studies providing data showing that CGA is useful are relatively scarce. 
This is the main reason why we chose to perform a rigorous study testing whether a CGA-
based classification of elderly patients actually predicted a short-term outcome such as post-
operative complications. 
 
Outside of oncology, CGA is an established tool to plan the management of frail, older 
individuals with complex medical needs15,78. A recent systematic review and meta-analysis 
found that inpatient rehabilitation specifically designed for geriatric patients had the potential 
to improve outcomes related to function, admission to nursing homes, and mortality79. Inside 
oncology, only a few studies have studied the impact of CGA. In a pilot study that included a 
small cohort of elderly patients with early breast cancer, Extermann and colleagues identified 
on average six initial problems detected by CGA and three new problems during follow-up80. 
They found that 87% of the problems, such as pharmacological, psychosocial, and nutritional 
risks, could be successfully addressed. Another prospective study of CGA in cancer patients 
found that in patients with a good Eastern Cooperative Oncology Group performance status 
(ECOG PS), about 10% had limitations in ADL, while about one third had limitations in 
IADL81. CGA has also been shown to provide information regarding survival in cancer 
patients, but the completeness of the CGA assessments varied between the studies. In a study 
of 566 patients aged 70-84 with stage IIIB or IV non-small-cell-lung cancer treated with 
chemotherapy, IADL score and performance status, but not ADL score and comorbidity, 
predicted survival82. Both ADL and IADL measurements predicted survival in a cohort of 252 
patients aged 65-94 with various cancers83. Performance status was not found to be a 
predictor of survival in a study of 155 patients aged 70-90 years with advanced ovarian 
cancer84. In the latter study, the presence of depressive symptoms (assessed merely by the 
judgment of the treating physician) was a significant predictor of mortality. A randomized 
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controlled trial of post-operative CGA in older post-surgical cancer patients with home visits 
performed by a nurse, demonstrated a survival benefit only in the patients with cancer in an 
advanced stage (hazard ratio 2.04, 95% confidence interval 1.33 to 3.12)85. In a secondary 
subset analysis of a randomized trial studying the benefits of treating frail older hospitalized 
adults in geriatric inpatient units compared to usual care, or geriatric outpatient units 
compared to usual care, Rao and colleagues found geriatric inpatient care in frail cancer 
patients to improve bodily pain, emotional limitation, and mental health (based on scores 
from self-reported quality of life questionnaires), but no survival benefit86. That study was 
based on data from Veteran Administration units in the US, and thus includes more than 90% 
men. 
 
Previous research regarding surgery in elderly 
patients with colorectal cancer 
Colorectal cancer surgery in the elderly has been addressed in a number of surgical 
publications in the last ten years71,87-123. Already in 1980, Boyd and colleagues elegantly 
showed that mortality rates after colon resection (70% of the patients had colon cancer) 
compared by decades of age correlated with the number of pre-existing conditions, and not 
with age as an isolated factor124. They concluded that a careful pre-operative assessment, 
correction of pre-existing pulmonary and nutritional deficiencies, and avoidance of 
emergency procedures might improve morbidity and mortality rates associated with colon 
resections in elderly patients. The exact same statement seems to hold true today. A large 
systematic review published in 2000 looked at how the outcomes of surgery for colorectal 
cancer differed between elderly and younger patients125. The cohort consisted of 34 194 
patients, and was divided into the following age groups: aged less than 65 years, aged 65-74 
years, aged 75-84 years, and aged 85+ years. Post-operative morbidity and mortality were 
found to increase with age. The authors proposed that this could be attributed to the following 
factors being more common with advancing age: comorbidity, the rate of emergency 
operations, and the rate of advanced cancer stages. They also found that elderly patients were 
less likely to undergo curative surgery. Overall survival was poorer for the older patients, but 
the differences in cancer-specific survival were less noticeable.  
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When studying the surgical literature regarding the impact of increasing age on surgical 
outcomes, methodological differences complicate a direct comparison between published 
studies. Some of these methodological issues will be discussed below.  
 
Differences in recording and presentation of pre-operative patient variables 
(age, comorbidity, functional status, nutritional status, cognitive function) 
There is no consistent definition of what constitutes the elderly. The most commonly used 
cut-offs when comparing a younger to an older population are 70, 75, or 80 years. Thus, the 
term “elderly” always needs to be specified. 
 
The influence of comorbidity on treatment and outcomes in older cancer patients is not well 
understood, except that comorbidity influences survival126-128. Some studies indicate that a 
few specific diseases matter129, but the overall burden of disease may be as important. 
Unfortunately, specific comorbidities and the severity of comorbidities are often not 
registered pre-operatively in surgical publications. Instead, American Society of 
Anesthesiologists physical status class (ASA class) is employed as a sole measure of 
comorbidity. ASA class distinguishes between no systemic disease, mild systemic disease, 
and severe systemic disease. I searched MEDLINE for English-language articles published in 
the last 10 years until October 1, 2010, that reported the results of studies about age and 
colorectal cancer surgery. I used the search terms: age, colorectal cancer, surgery, and 
surgical outcome. From the articles identified, I selected those for which the abstract 
indicated that the reported analysis investigated the impact of age on surgical outcomes. I 
found that 19 of 38 studies on age and the outcome after surgery for colorectal cancer 
included information about comorbidity beyond ASA class87,89,94-99,104,108,111,114,115,119,122-
124,130,131. Of these, only six included a comorbidity index94,97,99,122,123,130. Zingmond and 
colleagues studied predictors of serious medical and surgical complications after colorectal 
resections in 56 621 patients identified from the California hospital discharge database94. 
Independent predictors with the highest impact on developing serious medical complications 
were greater age, higher Charlson comorbidity index (CACI)132 score, and emergency 
surgery, while independent predictors of serious surgical complications were tumor location, 
greater age, and higher CACI score. Ouellette and colleagues evaluated CACI as a predictor 
of morbidity and mortality in 239 patients with colorectal carcinoma97. They found that CACI 
correlated with a longer length of stay, peri-operative mortality, and overall mortality. 
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However, in their study, CACI did not predict which patients would have minor versus 
serious complications. In a retrospective registry study by Rabeneck and colleagues, 30-day 
mortality in elderly patients following surgery for colorectal carcinoma in the veteran affairs 
health care system was studied99. Unfortunately, emergency versus elective procedures were 
not included in the multivariate analyses in that study. They found that predictors of 30-day 
mortality after rectal and colon cancer resections were age > 65 years, comorbidity (measured 
by the Deyo index133), and marital status. A study by Rutten and colleagues about total 
mesorectal excision and age used comorbidity data to show that comorbidity increased with 
increasing age up to 85-89 years, but they did not study the impact of comorbidity on post-
operative morbidity or mortality120. Tan and colleagues studied a population of 121 
octogenarians undergoing colorectal cancer surgery. In multivariate analyses, ASA class III 
and CACI scores ≥ 5 were independent predictors of morbidity. Of note, only 13 (12.4%) of 
their patients were ASA class III, and the majority of their octogenarians were actually ASA 
class I. In the Preoperative Assessment of Cancer Patients (PACE) study, the association of 
geriatric domains (ADL, cognition, depression, and comorbidity), performance status, and 
fatigue with surgical outcomes in a heterogeneous sample of 460 cancer patients was 
studied122. The majority of the patients in PACE had breast cancer (47%), while 31% had 
colorectal cancer. PACE did not include nutritional data. Independent predictors of surgical 
morbidity were fatigue and dependence in IADL. Comorbidity, measured by Satariano’s 
index of comorbidities134, was not an independent predictor of post-operative morbidity in 
PACE. The 13 remaining publications that registered comorbidity beyond ASA class used a 
variety of comorbidity lists, and registered from five to eight individual diseases such as for 
example cardiovascular disease, pulmonary disease, or diabetes. Furthermore, some studies 
included the absolute number of comorbidities in their analyses, while others looked at the 
predictive value of specific diseases for the outcome in question. As a consequence, the 
general impact of comorbidity on surgical outcomes is difficult to establish. Comorbidity 
increases with increasing age, and studies of independent risk factors for surgical morbidity in 
the elderly should include a standardized comorbidity assessment in order to untangle age 
from comorbidity. In fact, in the above mentioned systematic review from the Colorectal 
Cancer Collaborative Group, it was not possible to study the impact of comorbidity because 
too few studies had included such data125. However, it is still unclear how to optimally assess 
comorbidity in the surgical setting. Interpretation of comorbidity data is also influenced by 
how comprehensively comorbidities are registered. For example, comorbidity data that are 
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extracted from medical charts, administrative claim data, or registry data will usually be far 
less complete than data based on additional consulting with the primary care physician, the 
patient, and caregivers. In a study by Puig-La Calle and colleagues on rectal cancer resection 
in the elderly, 32% of patients younger than 75 years had hypertension, while only 31% of 
patients older than 75 years had hypertension. This seems counter-intuitive. If their elderly 
group was very selected and included mostly fit patients, it could explain the findings. An 
alternative explanation may be that hypertension was under-diagnosed in the elderly. The 
diagnosis of hypertension in the study was established through “chart review and telephone 
interview, when possible”. In the discussion, the authors point out that there is a correlation 
between a history of hypertension in elderly patients and post-operative urinary retention, and 
they discuss possible mechanisms. However, the validity of the hypertension data is not 
questioned in the discussion.  
 
Interestingly, only eight of the 38 studies mentioned above included data regarding the 
functional status of the patients pre-operatively71,92,97,102,108,114,122,123. Two studies used the 
Karnofsky Performance Status Scale, while two other studies used the Eastern Cooperative 
Oncology Group Performance Status (ECOG PS). The remaining four studies included 
information about form of residence or activities of daily living. Functional status was found 
to be an independent predictor of post-operative mortality in three studies71,97,114, while two 
other studies did not include functional status in the multivariable models92,108, and one study 
did not explain how multivariate analyses were performed102. In a study from Japan, only 
three of 121 octogenarians were ADL dependent, and ADL dependency was not found to 
predict morbidity in bivariate analysis123. In PACE, ECOG PS was a significant predictor of 
post-operative complications in bivariate analysis, but not in multivariate analysis when 
fatigue and IADL were included in the model122. However, it seems that functional status is a 
valuable pre-operative predictor in elderly patients undergoing surgery, and this variable 
should be included in surgical publications. 
 
Nutritional risk is associated with increased post-operative morbidity and mortality after 
elective surgery135. Seven of the 38 studies on age and colorectal cancer surgery included 
some form of pre-operative nutritional information: two studies recorded weight loss102,115, 
while five included body mass index89,110,111,123,131. Nutritional status is of particular interest 
pre-operatively in elderly patients for at least three reasons: malnutrition is frequent in the 
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elderly, weight loss may be related to frailty, and nutritional status may be improved by peri-
operative interventions.  
 
The risk of cognitive dysfunction increases with increasing age, and it has been shown that 
the risk of post-operative delirium is strongly related to pre-operative cognitive dysfunction. 
Only PACE of the studies mentioned above included information about cognition, through the 
Mini Mental State Examination (MMSE)122. Cognitive dysfunction was not found to be a 
predictor of post-operative morbidity in PACE, however, PACE did not include post-
operative delirium in their thirty-day morbidity checklist. 
 
Differences in recording and scoring of post-operative 
complications after surgery for colorectal cancer 
Estimates of morbidity after colorectal cancer procedures are commonly reported around 20% 
to 30%. The methods for registering complications grossly influence the reported rate136. 
Additionally, a common complication in elderly surgical patients such as post-operative 
delirium is frequently not recognized in clinical practice, and in many cases not even 
considered in surgical publications. Morbidity is higher in emergency surgery, and series of 
elective procedures are not directly comparable to mixed series including both elective and 
emergency procedures. In summary, reported complication rates are not necessarily 
comparable between studies.  
 
There seems to be a lack of consensus on how to define and grade the severity of post-
operative complications. It is obviously a difference between getting a post-operative lower 
urinary tract infection and an anastomotic leakage. Post-operative complications are often 
presented as minor or major, without a clear definition of the difference, for example in 
PACE122. Several publications make a distinction between surgical and medical complications 
without clearly defining the difference. Post-operative complications, surgical or medical, 
increase lengths of stay, costs, disrupts quality of life, and may lead to an increased long-term 
mortality120,137. A standardized scoring system for post-operative complications similar to the 
Common Toxicity Criteria used in studies of adverse effects of chemotherapy would make it 
easier to compare results from surgical studies. One such classification system for post-
operative morbidity was presented by Clavien and colleagues in 1992138. This system uses a 
broad definition of complications: “any event requiring treatment measures not routinely 
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applied post-operatively”. Scoring is based on a pragmatic approach, relying mostly on the 
therapy used to treat the complication. Thus, it is a practical grading system for post-operative 
complications. Clavien and colleagues specifically stated that their aim was to “define 
relevant terms and propose a system of classifications of complications based on severity that 
can act as a standard reporting guide”. Even though the authors used elective cases of 
cholecystectomies to illustrate the relevance of their classification, the scoring system was 
never designed solely for post-cholecystectomy complications. On the contrary, the authors’ 
main purpose was to create a system for standardized reporting of complications, and they 
state that they have “proposed a general classification of complications and applied this 
classification specifically to cholecystectomy”. This is further illustrated by the fact that 
Clavien’s classification system has been used in other studies of post-operative morbidity in 
gastrointestinal surgery, such as in patients with colorectal carcinoma97, and in elderly 
patients undergoing liver resections139. 
 
Differences in peri-operative care 
The outcomes after colorectal cancer surgery are highly influenced by the peri-operative care 
provided for each patient. For example, it has been demonstrated that an enhanced recovery 
after surgery program (ERAS) for elective bowel surgery may reduce morbidity, lead to a 
faster recovery, and shorten hospital stay140,141. This accelerated multimodal rehabilitation 
program includes, among other factors, optimal pain relief, stress reduction with regional 
anesthesia, early enteral nutrition, and early mobilization. Another strategy that was recently 
shown to substantially improve surgical quality was the implementation of surgical checklists 
during different phases of pre-operative, intra-operative, and post-operative care142. In the 
western health region of Norway, an ongoing research project is evaluating the effect of 
implementing the Surgical Safety Checklist recommended by the World Health Organization. 
Exploring potential differences in peri-operative care between hospitals was not within the 
scope of our study, nevertheless, some of the literature regarding peri-operative care will be 
discussed below. 
 
Peri-operative care and the evidence in older colorectal cancer patients  
Approximately 40% of colorectal cancer patients are 75 years and older, while approximately 
24% are aged 65-74 years. In other words, the majority of patients, about 64%, is 65 years 
and older. However, in surgical studies dealing with elements of peri-operative care in 
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patients with colorectal cancer, it is surprisingly rarely discussed that the clinical applicability 
of results from trials is largely dependent on whether the study participants represent the 
population in interest. On rare occasions, the importance of age, comorbidity, cognitive 
function, polypharmacy, and functional status are mentioned. As discussed earlier, it is well 
known from other fields of medicine that older cancer patients are underrepresented in clinical 
trials143,144, and this seems to hold true for many surgical publications as well. It may be 
argued that there is no reason to believe that the results of clinical trials in surgical patients 
would differ if the study population was older and reflecting the actual age and fitness level of 
the patient population, but this question remains largely unanswered. Within the oncology 
field, there may be changes in the biological behavior of tumor and responsiveness to 
treatment with age, and as discussed earlier little is known about how cancer treatments 
interact with the vulnerability of aging people. From a physiological perspective, it is well 
known that the aging process leads to several important changes that limit a person’s reserve 
capacity, especially when the body is subject to stress such as surgery. An interesting example 
relevant in this setting is the question about whether the implementation of TME in curative 
rectal cancer surgery has been beneficial to the patients aged 75 years or older. TME is the 
standard of care for resectional treatment of rectal cancer, and was established in Norway in 
1994. Population-based registries in the Netherlands and Norway have been used to study the 
effects of implementing this technique in the general patient population. Based on cancer 
registry data, Rutten and colleagues have concluded that the implementation of TME in the 
Netherlands did not improve 5-year survival in patients 75 years or older, and the 6-month 
mortality in this patient group after TME surgery remained substantial at 14%130. The authors 
state that this example illustrates the importance of being careful when extrapolating results 
from studies done in younger surgical patients to older patients120. In contrast, in a Norwegian 
study by Nedrebo an colleagues145, relative survival for rectal cancer was significantly 
improved also for patients older than 75 years between the early (1994-1996) and late (2001-
2003) time periods that were studied. These two studies are not directly comparable, as Rutten 
and colleagues look at overall survival, while Nedrebo and colleagues calculated relative 
survival. The two studies reach opposite conclusions, and illustrate the complexity of decision 
making in older patients where the “hard” evidence is scarce. 
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Multimodal peri-operative interventions 
A general goal in surgery is to use the minimal anesthesiological time necessary and to 
minimize the surgical trauma. Re-establishing natural functions, such as eating and moving 
around as soon as possible after surgery, is beneficial for surgical outcomes. As this is a 
multidisciplinary issue, it should be the focus of all healthcare professionals dealing with the 
surgical patient as well as the patient himself. In older patients, where comorbidities and 
reduced functional reserves make patients especially prone to the negative effects of bedrest 
and the surgical trauma, a multidisciplinary approach to a speedy recovery may be even more 
important. As an example, a multicomponent intervention effectively reduced the prevalence 
of post-operative delirium in older surgical patients with hip fracture47,146. On the other hand, 
patient factors may make early mobilization and a quick recovery more challenging in older 
adults. 
 
When studying elements that may improve the peri-operative course, addressing single factors 
in isolation may be less interesting than addressing a variety of factors simultaneously. 
Logically, optimizing all aspects of peri-operative care at the same time using a multimodal 
approach may be the most efficient way to organize care. For colonic surgery, this has been 
implemented and tested through the enhanced recovery after surgery (ERAS) program, also 
called fast-track (FT) surgery141,147. The aim of this program is to enhance post-operative 
recovery and to avoid obstacles to early hospital discharge, for example post-operative 
complications, the need for parenteral analgetics, and delayed patient mobilization. Main 
elements of this program are pre-operative counseling, no bowel preparation, no 
premedication, no pre-operative fasting, tailored anesthesia, avoidance of fluid overload, no 
routine use of nasogastric tubes, and early post-operative feeding and mobilization. A 
metaanalysis from 2006 included randomized or clinical controlled trials that compared two 
prospectively included groups receiving either FT surgical care or traditional care (TC) for 
benign or malignant colonic resections148. Six studies were included in this metaanalysis; 
three randomized and three controlled clinical trials. The metaanalysis supported the FT 
approach to colonic surgery because it was associated with fewer post-operative 
complications and a shorter length of stay. The three randomized trials (RCT) in the 
metaanalysis included patients with a mean age ranging from 42 to 68 years149-151. Two of the 
controlled trials had a mean age of included patients of 60-65 years (14, 15), while one study 
by Basse and colleagues included two groups of patients with mean ages of 72 and 74 years, 
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respectively152. The study by Basse included a total of 260 patients, and data regarding the 
control group (TC) were collected retrospectively and from a different hospital than data 
regarding the FT group. Comorbidity seemed to be more common in the FT group, and a 
possible explanation was that data from the FT group, as opposed to those from the TC group, 
were collected prospectively. However, this may not entirely explain the differences, since 
ASA class was also higher in the FT group. The rate of medical complications was lower in 
the FT group, especially cardiopulmonary complications. On the other hand, the rate of 
readmissions was higher in the FT group (20% compared to 12%), with 6 of the 27 
readmissions being due to social factors. In an observational study of 60 patients with a 
median age of 74 years, a similar clinical pathway to enhance recovery after colonic resection 
successfully reduced length of stay147. In that study, 16 patients were older than 80 years, 18 
had impaired mobility, and comorbidity was reported as frequently occurring, indicating that 
even frail patients may benefit from a FT program. However, as the authors note, for such an 
early discharge to be possible, it is vital that patients are able to contact the hospital 
immediately if there are signs of post-operative complications. In older patients, where 
cognitive dysfunction is relatively common, this early discharge approach calls for a cognitive 
screening pre-operatively. The use of a FT post-operative management protocol in patients 
undergoing colonic and rectal surgery was also addressed by Delaney and colleagues153. The 
median age of included patients in their study was only 44.5 years (range, 13-70), while 40 of 
the 58 patients were classified as “with comorbidity”. The authors concluded that patients 
with a high level of comorbidity benefit from a FT program. 
 
In conclusion, there are limited data indicating that a FT multimodal approach to colonic 
surgery in older patients may be beneficial. To my knowledge, the importance of functional 
status, comorbidity, cognitive function, social support, and emotional status on feasibility and 
outcome in older patients undergoing colonic resections in a fast track program remain largely 
unknown, and further studies addressing these issues are warranted. 
 
Peri-operative factors influencing post-operative outcome in older patients 
Surgical checklists 
A recent publication studied the effects on patient outcomes of a comprehensive, 
multidisciplinary surgical safety checklist142. Included items were for example pre-operative 
nutritional screening, medication use both before surgery and at discharge, and instructions to 
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patients concerning dietary factors.  Interestingly, the checklist used in the study also included 
delirium screening and prevention. The implementation of checklists resulted in a significant 
reduction in post-operative complications. Even though this was studied in adults undergoing 
general surgery, it is relevant in this setting because it shows the importance of organizational 
routines on surgical outcomes.  
 
Patient information 
It has been suggested that standardized pre-operative information and counseling to the 
patient impacts the peri-operative course140. The evidence is limited, and to my knowledge it 
has not been studied in older patients154,155. The recommendation by the ERAS group is to 
present the patient with information about pain, pain treatment, his or her role in the post-
operative process with an emphasis on the benefits of early mobilization, and the expected 
length of stay140. Older patients in particular may have unrealistic expectations about the 
hospital stay after surgery, as the length of stay after a surgical procedure frequently exceeded 
two weeks 30-40 years ago. In patients with cognitive dysfunction, pre-operative counseling 
may pose a challenge, but it is not unreasonable to hypothesize that informing caregivers of 
the importance of early mobilization and expected length of stay will be beneficial.  
 
Pre-operative bowel preparation 
Pre-operative bowel preparation may lead to disturbances in the fluid- and electrolyte balance 
and dehydration140. Based on available evidence, it is not indicated for elective colon cancer 
surgery except when intra-operative colonoscopy is needed156,157. Two randomized trials have 
studied this; one of them included patients with a mean age of 69 years156, while the other trial 
did not present the age of the included patients157. For lower resections, the findings from 
studies are inconsistent, and further trials are needed to establish the optimal approach for 
bowel preparation in patients undergoing lower resections140.  
 
Pre-operative fasting and carbohydrate load 
Fasting before surgery deprives patients of nutrition and hydration. A Cochrane review from 
2003 concludes that there is no evidence to support that a shortened fasting period for fluids 
leads to more aspiration, regurgitation, or related morbidity than longer fasting periods158. 
However, the authors also state that elderly patients are more likely to regurgitate under 
anesthesia (possible causes are reduced tone of the lower esophageal sphincter, a greater 
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incidence of hiatal hernias, and increased gastrointestinal reflux), and more research is needed 
to establish whether these patients can also safely drink up to a few hours before surgery. The 
general recommendation is that the pre-operative fasting period does not need to exceed two 
hours for clear liquids and six hours for solid food140. It has also been suggested that a pre-
operative carbohydrate load may be beneficial in order to avoid for example muscle loss after 
surgery. This may be particularly important for older patients, specifically frail older adults, 
because they already have a limited muscle mass. One of the randomized trials studying the 
effect of an oral carbohydrate-containing fluid load found that it was safe and potentially 
attenuated depletion of muscle-mass159. However, the mean ages of included subjects in the 
two study groups were only 52 and 53 years, respectively. Another randomized trial of pre-
operative carbohydrate loading assessed effects on grip strength, gastrointestinal function, and 
hospital stay160. That study included patients with a mean age of less than 60 years. The 
results showed a shorter hospital stay for the group receiving carbohydrates. Relevant in the 
context of frailty, the fasted group had a statistically significant reduction in post-operative 
grip strength as opposed to the carbohydrate group and yet another group receiving pre-
operative oral water compared to pre-operative levels. However, the grip-strength results were 
difficult to interpret because they showed considerable fluctuations throughout the post-
operative course160. 
 
Premedication, prophylactic antibiotics, and prevention of post-operative nausea 
Premedication that does not cause post-operative drowsiness is recommended, as drowsiness 
may increase the risk of post-operative delirium and hamper early mobilization161. For colonic 
and rectal procedures it is recommended to administer pre-operative prophylactic antibiotics 
against both aerobic and anaerobic microbes one hour before surgery. This reduces the rate of 
post-operative surgical site infections and sepsis162.  If the procedure lasts more than three 
hours, a subsequent dose should be administered161. It has also been suggested to provide the 
patient with medication to prevent post-operative nausea, such as dexamethasone or serotonin 
antagonists. The risk of developing post-operative nausea varies between patients, and risk 
factors include being female, history of motion sickness, post-operative administration of 
opioids, and having a nonsmoking status163. In a randomized trial of prevention of post-
operative nausea and vomiting by metoclopramide combined with dexamethasone, it was 
found that early post-operative nausea and vomiting was less frequent in patients aged 50 or 
more, but late episodes were more frequent, as were adverse reactions164. 
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Anesthesia 
According to Norwegian guidelines, the optimal anesthestic protocol for colorectal 
procedures is yet to be decided161. As long-acting, intravenously administered opioids may 
interfere with the goals of early mobilization, it seems more optimal to use short-acting 
agents140. For the same reason, premedication such as hypnotics, long-acting sedatives, and 
opioids should be avoided. The use of intraoperative epidural analgesia may be beneficial 
because it might decrease the need for general anesthetic agents. The aging process affects the 
pharmacokinetics and pharmacodynamics of many drugs, including drugs used in anesthesia. 
This is true for both inhaled anesthetics, where minimum alveolar concentration (MAC) that 
prevents movement in response to noxious stimulation decreases with age, and for injectable 
anesthetic and sedative drugs165. A discussion of the mechanisms responsible for these 
changes is beyond the scope of this thesis. 
 
Nasogastric decompression 
Nasogastric decompression is not recommended as a routine measure for colorectal surgery. 
Extensive evidence suggests that patients who do not receive routine nasogastric tubes have 
an earlier return of bowel function as well as fewer pulmonary complications166. Thus, a 
selective use of nasogastric decompression is recommended. 
 
Peri-operative fluids 
Overhydration of patients undergoing bowel surgery may cause intestinal paralysis, edema, 
diminished tissue oxygenation, and potentially weakened strength of the anastomosis140. 
Thus, it has been suggested that more restrictive regimens for fluids are beneficial. The 
evidence suggests regimens that maintain body weight, but hypovolemia should be 
avoided167. Epidural and spinal anesthesia may cause hypotension due to a blockage of the 
sympathetic nervous system leading to vasodilatation, even if the blood volume remains 
unchanged168. Consequently, this may be better treated with vasopressors than with excessive 
fluids, especially in patients with cardiopulmonary disease. In an RCT studying the effect of 
salt and water balance on recovery of gastrointestinal function after elective colonic resection 
it was concluded that a positive salt and water balance sufficient to cause a 3 kg weight gain 
after surgery delayed return of gastrointestinal function and prolonged hospital stay167. The 
mean ages of patients in the two study groups were 59 and 62 years, respectively. However, 
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another RCT studying 32 patients receiving liberal versus restrictive fluid regimen in a FT 
program found that morbidity tended to be increased in patients receiving the restrictive 
regimen168. The mean ages of the patients in the latter study were 74 and 77 years, 
respectively. From a physiological point of view, alterations in the cardiovascular system are 
likely to make older patients more sensitive to fluid shifts, and elderly-specific trials regarding 
peri-operative fluid therapy are desirable. Blood vessel distensibility is decreased in older 
individuals, and population-based data show that the majority of older adults suffer from 
hypertension14. Furthermore, a genuine age-related change in the heart is an approximately 
30% increase in the thickness of the left ventricular wall, and the left ventricle may be stiff 
due to increased collagen content with age14. Thus, the heart is dependent on adequate preload 
to maintain cardiac output. As baroreflexes are frequently blunted with increasing age, the 
response to hypovolemia may be inadequate in older patients165. It is well known that older 
adults have an increased risk of orthostatic hypotension with drug therapy.   
 
The use of urinary catheters 
A recent meta-analysis comparing suprapubic and transurethral catheterization for bladder 
drainage after abdominal surgery found that the suprapubic route lead to fewer urinary tract 
infections and was more acceptable to patients169. Especially in rectal cancer surgery, which 
usually requires a prolonged use of a urinary catheter, a suprapubic catheter allows for greater 
mobility. For colonic resections, the catheterization period is shorter. An uncontrolled study 
including 100 patients with a median age of 72 years undergoing colonic resection who 
received thoracic epidural analgesia, found that removing the urinary catheter on the first 
post-operative morning resulted in low incidences of urinary retention and urinary tract 
infections147.  
 
Post-operative ileus 
A Cochrane review from 2000 found that gastrointestinal paralysis was reduced when 
epidural local anesthetics were used instead of opioid-based analgesic regimens in patients 
undergoing laparotomy170. It remains unclear whether the ileus-reducing effect of epidural 
local anesthetics is due to the effect of using epidural analgesia per se, or due to the 
concurrent avoidance of gastric tubes and early institution of oral nutrition152. The combined 
positive effect of continuous epidural analgesia, early mobilization and oral nutrition, 
cisapride (gastroprokinetic agent) and laxative treatment with magnesium was demonstrated 
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in a small study that included patients with a mean age of about 72 years undergoing colonic 
resection171. In that study, normal gastrointestinal transit was established within 48 hours 
post-operatively, instead of the more commonly experienced two to five days. 
 
Post-operative pain management 
Post-operative pain management is essential for early mobilization. A recent meta-analysis 
compared the effects of epidural analgesia to systemic opioid analgesia after colorectal 
surgery172. The authors found that epidural analgesia significantly reduced post-operative pain 
and the duration of ileus, but on the other hand it was associated with pruritus, urinary 
retention, and arterial hypotension. The mean ages of the patients included in the randomized 
trials comprising the meta-analysis were not reported. Paracetamol is also recommended for 
post-operative pain management, and studies suggest that non-steroid anti-inflammatory 
drugs (NSAIDs) reduce the need for opioids140. However, due to the side effect profile of 
NSAIDs, caution is required when using NSAIDs in older patients.  
 
Oral nutrition 
Post-operative feeding should start as soon as possible after surgery. There is apparently no 
increased risk of anastomotic leak, and early continuation of feeding reduces length of stay 
and may also reduce the rate of post-operative complications140. In a study from 2001 
investigating whether an early feeding protocol in older (70+ years) patients undergoing 
elective open colonic resection would result in early discharge and low morbidity, it was 
found that close to 90% of patients tolerated early feeding173. Comorbidity was not reported 
beyond ASA class in that study, but functional status was recorded. Only one of the 87 
included patients was dependent in ADL, suggesting a highly selected older study cohort.  
Beattie and colleagues showed that malnourished patients, as defined by a body mass index ≤ 
20, anthropometric measurements ≤ 15th percentile on admission or on resumption of the oral 
diet, and/or a weight loss of 5% or more from admission until oral intake was resumed, 
profited from post-operative oral nutritional supplements for eight weeks in terms of recovery 
of nutritional status, protein economy, and quality of life174. The mean ages of the subjects in 
that study were 54 years in the treatment group and 62 years in the control group. 
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Early mobilization 
Early mobilization is a key principle in geriatric medicine as well as in post-operative surgical 
care. Prolonged bedrest has a negative impact on several bodily functions, and may among 
other things lead to muscle loss, bone loss, insulin resistance, decrease in cardiac output, 
baroreceptor desensitization and orthostatic hypotension, atelectasis, and pulmonary 
dysfunction, and thereby increase the risk of pneumonia, pressure ulcers, thromboembolism, 
and falls. Early mobilization may be obtained through specific treatment measures such as 
optimal pain relief, minimal use of immobilizing equipment (urethral catheters, physical 
restraints), and through specific actions to encourage ambulation. Examples are preplanned 
structured mobility schedules, removal of television in the hospital rooms, designated dining 
rooms in the wards to prevent meal intake in bed, a uniform focus on ambulation from all 
members of the health care team, and continuous information to caregivers and patients about 
the importance of ambulation. If ambulation is not possible, range of motion exercises and the 
maintenance of an upright posture should be emphasized. 
 
Intra-operative variables influencing surgical outcomes 
Laparoscopy assisted versus open surgery 
Several short-term outcomes, such as blood loss, wound complications, post-operative pain, 
and length of stay, have been improved when performing laparoscopic surgery. A systematic 
review published in 2006 concluded that laparoscopic resection for colon and rectosigmoid 
cancer is feasible, safe and has many short-term benefits175. However, the age of patients 
included in the studies that comprise the review is not discussed. In the COLOR trial, where 
1082 patients with colon cancer were randomized to open versus laparoscopic surgery, the 
mean age in the two study groups was 71 years176. In that study, patients assigned to 
laparoscopic resection had less blood loss, earlier recovery of bowel function, and a shorter 
hospital stay. Morbidity and mortality did not differ between the two groups. The authors 
specifically emphasized that elderly patients were not excluded from the study. Yamamoto 
and colleagues investigated the effect of laparoscopic colonic surgery in a small sample of 
octogenarians, and found that there were no significant differences between the older group 
and a group of patients aged 60 years and younger in terms of the incidence of complications, 
the interval before resumption of liquid or solid food intake, or length of hospitalization177. 
Similarly, Sklow and colleagues found that patients older than 75 years who underwent 
colectomy for colorectal cancer improved more rapidly in their bowel function after 
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laparoscopic than after open surgery, as did younger patients178. There were no differences in 
independence at discharge according to type of surgery. The study by Sklow and colleagues 
was a retrospective review, while the study by Yamamoto and colleagues was a matched case-
control study. Stewart and colleagues prospectively evaluated patients 80 years or more 
undergoing elective laparoscopic or open colorectal procedures between 1992 and 1997, and 
found that laparoscopically assisted colorectal surgery was safe and associated with a low 
incidence of complications, short hospitalization, and a rapid return to pre-operative activity 
levels179. Major intercurrent disease was found in 63 of 77 patients, indicating a representative 
patient cohort. It has, however, been questioned whether the favorable results of laparoscopic 
surgery compared to open resections are due to improved organization of peri-operative care 
rather than the procedure itself152. In conclusion, laparoscopic surgery now seems to be an 
acceptable alternative to open surgery for colon cancer, but more data are warranted. When 
patients are operated within a FT program, the benefits from laparoscopic surgery, especially 
the decreased length of stay, seem less clear. A randomized controlled trial is underway to 
compare laparoscopic versus open colonic surgery within a FT setting, and hopefully this 
study has included a representative cohort of patients with respect to age180.  
 
For rectal cancer, it is less clear whether laparoscopic surgery provides advantages compared 
to open surgery161. 
 
Surgery for colon versus rectal cancer 
In Norwegian guidelines, rectum is defined as bowel 15 cm or less from the anal verge, 
measured from the lower tumor border by rigid proctoscopy. Patients with rectal cancer are 
treated by a different surgical protocol than patients with colon cancer. The multidisciplinary 
team is crucial in deciding treatment plans for rectal cancer patients, including whether 
multimodal therapy is necessary. The main goals of treatment are to prevent local recurrence 
and secure long-term survival with a minimum of side effects. Rectal cancer rarely requires 
emergency surgery, but is associated with more frequent complications than cancer surgery in 
other parts of the large bowel94,181-186. Usually, the risks of anastomotic leak, delayed perineal 
wound closure, and other post-operative complications are higher in rectal cancer surgery, and 
pre-operative use of chemoradiation increases the risks further186. Anastomotic leak, in 
addition to impacting the immediate post-operative mortality and possibly the risk of local 
recurrence, has been associated with a significantly worse long-term survival in patients 
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undergoing curative resection for colorectal cancer187. Patients with rectal cancer are a 
heterogeneous group because of differences in tumor size, tumor location, lymph node 
involvement, and the varying use of neoadjuvant treatment. The Norwegian National Rectal 
Cancer Registry was established in 1993, and data regarding all patients over 65 years 
operated between November 1993 and December 2001 have been published188. The age 
groups 65-74, 75-79, 80-84, ad 85 and older were compared. The rates of local treatment and 
palliative treatment increased with increasing age, regardless of tumor stage. In the younger 
group, 77% received curative resection, compared to 47% in the oldest group. The paper does 
not contain information about comorbidity or functional status. In patients treated for cure, the 
use of both pre-operative and post-operative radiation therapy decreased with age. The rate of 
post-operative mortality was 8% for the oldest group compared to 3% for the youngest group 
(p<0.001). Relative five-year survival was lower in the oldest group compared to the youngest 
group, but there was no consistent age-related trend: The relative five-year survival in patients 
treated for cure were 77%, 70%, 72%, and 65% for the four groups, respectively. 
 
Existing pre-operative risk assessments of surgical patients 
In Norway, the anesthesiologist assigns the patient to an American Society of 
Anesthesiologist physical status class (ASA class) pre-operatively. ASA class is related to 
outcomes after surgery, but does not incorporate type of operation. In the Norwegian 
translation of the ASA classification that is published by the Norwegian Society of 
Anesthesiologist, patients aged over 80 years are automatically assigned to ASA class II or 
higher, regardless of physical status. In a study of octogenarians undergoing colorectal 
surgery from Japan, however, 51/121 patients were classified as ASA class I123. Thus, the 
association between ASA and surgical outcomes in the elderly may be difficult to compare 
between studies. Furthermore, surgical studies often include a mix of emergency and elective 
procedures, which further complicates a direct comparison of study outcomes. Tan and 
colleagues found in their study of octogenarians from Japan that ASA class (≥3 versus <3) 
was an independent predictor of morbidity123, while a French study (all ages) did not find that 
ASA class independently predicted morbidity189. In a large study of surgical risk factors and 
morbidity in elderly patients (major general, general thoracic, and vascular surgical 
procedures), Turrentine and colleagues found that ASA class was an independent predictor of 
collective post-operative morbidities in the 60- to 79-year age group, but not in the 80- to 
103-year age group190. In the older group, the most frequent predictors of collective post-
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operative morbidities were pre-operative transfusion, emergency operation, weight loss, 
operative duration, and chronic obstructive pulmonary disease.  
 
The APACHE (Acute Physiology and Chronic Health Evaluation) II index and POSSUM 
(Physiological and Operative Severity Score in Enumeration of Mortality and Morbidity) are 
examples of surgical assessment scales. The APACHE II includes twelve physiological 
indicators (heart rate; respiratory rate; mean arterial blood pressure; temperature; 
oxygenation; arterial pH; serum sodium concentration; serum potassium concentration; 
packed-cell volume; white-blood-cell count; serum creatinine concentration; score on the 
Glasgow coma scale), as well as age and the presence or absence of severe chronic health 
problems. The tool is usually used in the intensive care setting. APACHE II provides limited 
information pre-operatively regarding the suitability of an elderly patient to undergo cancer 
treatment, but may be more relevant in the immediate post-operative period. POSSUM was 
developed as a surgical audit tool in 1991, and has been shown to predict morbidity and post-
operative mortality in general surgery. The scale includes 12 physiological parameters (age, 
cardiac history, respiratory history, blood pressure, pulse rate, Glascow coma scale, 
hemoglobin level, white cell count, urea concentration, sodium level, potassium level, and 
electrocardiography) as well as six operative parameters (operative severity, multiple 
procedures, total blood loss, peritoneal soiling, presence of malignancy, and mode of 
surgery). POSSUM has been shown to overestimate post-operative morbidity and mortality in 
younger patients, and to underestimate mortality in older patients110,118,123,191. Colorectal-
POSSUM (CR-POSSUM) was developed in 2004, and is specific to colorectal surgery192. It 
was shown to perform better than POSSUM in a cohort of patients undergoing surgery for 
complicated diverticular disease191. Since it uses operative variables, CR-POSSUM cannot be 
used as a pre-operative decision making tool. Another mathematical model for prediction of 
operative mortality in colorectal cancer is the colorectal cancer model of the Association of 
Coloproctology of Great Britain and Ireland (ACPGBI)193. This tool can be accessed online 
(http://www.riskprediction.org.uk/index-crc.php), and it includes patient age, cancer resection 
status, ASA class, cancer stage, and operative urgency. 
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Aims of the present study 
The aims of the present study were to investigate whether a comprehensive geriatric 
assessment could predict short-term and long-term outcomes after elective colorectal surgery 
in elderly patients. Furthermore, we wanted to explore two different methods of identifying 
frailty in the context of colorectal cancer surgery in the elderly. More specifically, the aims 
were: 
 
a. To prospectively study a pre-operative categorization of elderly patients with 
colorectal cancer into three groups fit, intermediate, and frail, based on a CGA, and to 
analyze the ability of this classification to predict post-operative complications 
b. To prospectively analyze the predictive ability of the elements of a pre-operative 
CGA, both for post-operative complications and overall survival 
c. To compare two different approaches to identifying frailty in elderly patients with 
colorectal cancer, a multi-modal CGA-based frailty measure and a modified version of 
the physical phenotype of frailty, and to analyze their predictive ability for post-
operative complications and overall survival 
d. To study the associations of proposed biomarkers of frailty with frailty defined from a 
CGA and from a modified version of the physical phenotype of frailty  
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Patients and methods 
All studies were conducted in different subsamples of 182 patients who were consecutively 
admitted to Ullevaal, Aker and Akershus University Hospitals from November 2006 through 
June 2008. Patients were identified from the routinely scheduled surgical programs at each 
hospital. At Ullevaal and Akershus University Hospitals, the patients were admitted to the 
hospital the day before surgery, and the assessment took place that day. At Aker, most of the 
patients were assessed after their outpatient pre-operative work-up, in most cases conducted 
one week prior to surgery. Patients operated at Aker University Hospital were most frequently 
admitted for same-day surgery. In Norway, all operations for colorectal cancer are performed 
in public hospitals, and patients are generally operated in the hospital that serves the patient’s 
residential area. All patients provided a written informed consent. The decision regarding 
whether a patient was eligible to provide consent was based on the judgment of the principal 
investigator (PI), a medical doctor with training in geriatrics. 
 
Two hundred ninety-six patients were scheduled for elective surgery for colorectal cancer in 
the three hospitals during the recruitment period. Of these, 101 were lost for independent 
logistical reasons. The most common reason was that the PI was not informed about the 
patients. Other reasons were changes in the operative schedule that were not communicated to 
the PI in a timely manner, unavailability of the PI due to mandatory PhD-courses or vacation, 
or that patients were scheduled for pre-operative work-up at two hospitals at the same time. 
Of the 195 patients assessed for eligibility, 10 were excluded pre-surgery. Five were not able 
to provide a written informed consent, three refused to participate, while two were deemed 
unfit for surgery. Of the 185 patients included in the study, three were excluded post-surgery. 
One did not undergo a resection, while the other two were re-operated for other reasons than 
complications. A flow chart is presented in paper I (Figure 1). 
 
Data regarding overall survival were obtained from the National Registry of Norway. 
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Assessment tools 
Comprehensive Geriatric Assessment 
The principal investigator performed a comprehensive geriatric assessment in all the study 
participants. All patients were interviewed, and the geriatric assessment forms were 
completed during the interview based on self-report. The interview and examination were in 
most cases carried out when only the patient was present. If permitted by the patient, 
caregivers were invited to join the interview. Thus, no multidisciplinary team was involved in 
the CGA assessments in this study, and no forms were self-administered.  
 
 
Table 1 presents an overview of the domains included in the comprehensive geriatric 
assessment and the tools that were used. The tools are described in more detail in the text 
below. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
47 
 
 
Table 1. Elements of CGA, tools utilized in the study, and cut-off scores for the 
various elements 
CGA-element Tool Cut-off scores Range 
Personal ADL Barthel index 
  Independent 
  Dependent 
 
19-20 
0-18* 
0-20 
Instrumental ADL Nottingham extended ADL scale 
  Independent 
  Dependent 
 
44-66 
0-43 
0-66 
Comorbidity Cumulative Illness Rating Scale 
  Mild 
  Moderate 
  Severe 
 
See text 
14 organ 
systems, 
severity grade 
0 to 4 
Polypharmacy Number of drugs in daily use 
  0-4 
  5-7 
  8 or more 
 
0-4 
5-7 
8 or more 
0 to 14 
Nutritional status Mini Nutritional Assessment 
  Normal 
  At risk 
  Malnutrition 
 
24-30 
17-23.5 
0-16.5 
0-30 
Cognitive Function Mini Mental State Examination 
  Good 
  Moderately Impaired 
  Cognitive Dysfunction 
 
27-30 
24-26 
0-23 
0-30 
Depression Geriatric Depression Scale 
  No depression 
  Depression 
 
0-13 
14-30 
0-30 
Abbreviations: CGA; comprehensive geriatric assessment, ADL; activities of daily living 
*In this study, patients with fecal incontinence due to rectal cancer were classified as 
independent if this was their only personal ADL limitation 
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The Barthel ADL index. The Barthel index includes 10 items assessing basic self-care abilities 
such as fecal continence, feeding, transferring from bed to chair and bathing/showering194. 
This index is well proven and widely used for the assessment of basic ADL functions. The 
index was used as a questionnaire for the retrospective assessment of ADL during the last two 
weeks. It has been suggested that the factor structure of the Barthel index depends upon the 
category of patients being studied. Among geriatric patients, two factors have been identified 
– one related to mobility, and the other related to bodily functions195. Among stroke patients, 
on the other hand, it seems that the Barthel index is unidimensional. The internal consistency 
of the Barthel ADL index in our study sample was measured by the Cronbach’s alpha 
coefficient. We found that the Cronbach alpha coefficient was 0.84, suggesting good internal 
consistency reliability for the scale with our sample. 
 
The Nottingham Extended ADL (NEADL) scale. The NEADL provides more comprehensive 
information about the patients’ ability to perform more complex activities than basic ADL 
functions. The scale consists of four subsections - mobility, kitchen, domestic and leisure 
activities, but according to previous research it may also be appropriate to add the subscales to 
provide an overall score196. NEADL was applied as an interview with the patients, and, in 
some cases, their caregivers provided supplemental information. In the current study, the 
Cronbach alpha coefficient was .89, suggesting very good internal consistency reliability for 
the NEADL scale in our cohort. 
 
The Cumulative Illness Rating Scale (CIRS). This comorbidity index allows scoring of the 
number of comorbidities, a measure of chronic medical illness burden, as well as the severity 
of comorbidity. CIRS has been extensively used in clinical series, and correlates with 
mortality, hospitalization rates and duration, hospital re-admission, medication usage, and 
functional disability in geriatric populations197-200. It has been validated in older cancer 
patients201. The detailed manual for the scoring of CIRS was revised and published in 2008, 
and this manual was used for CIRS scoring in our study200. The CIRS assesses 14 organ 
systems, and comorbidity in each organ system is scored on a five-point scale ranging from 0 
(no problem) to grade 4 (extremely severe/immediate treatment required/end organ 
failure/severely impaired function). Overall comorbidity was classified in the following way: 
mild/no comorbidity when there was no comorbidity higher than grade 2 and less than three 
grade 2 comorbidities, moderate comorbidity when there were a maximum of two grade 3 
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comorbidities and no grade 4 comorbidity, or severe comorbidity when there were at least 
three grade 3 comorbidities or any grade 4 comorbidity54,202. 
 
Polypharmacy. Polypharmacy is commonly included in a CGA, but how to classify 
polypharmacy in the context of frailty is not well established in the literature. In a Swedish 
study of individuals 65 years and older, 39% used five or more prescription drugs203. I our 
study, we simply counted the number of systemic drugs that the patients used on a daily basis. 
However, we did not study details regarding types of medications, possible interactions, or 
possible inappropriate drugs. 
 
The Mini Nutritional Assessment (MNA). MNA was developed to identify elderly at risk of 
malnutrition. The prevalence of malnutrition as measured by MNA varies greatly between 
different settings, but the mean rate is as high as 20% in hospitalized patients204. The MNA 
consists of a two-step procedure for screening followed by a full assessment. The screening 
part includes questions about food intake, weight loss, mobility, acute stress/disease, 
cognitive function, and body mass index. Because several of our patients had experienced 
weight loss, and all had suffered psychological stress or acute disease in the past three months 
(diagnosed with cancer), we completed the full MNA in almost all the patients. In 
hospitalized patients, low MNA scores are predictive of adverse outcomes including longer 
lengths of stay, more frequent discharge to nursing homes, and increased mortality204. 
 
The Mini Mental State Examination (MMSE). The MMSE is the most widely used screening 
test for cognitive impairment in general and in the assessment of older adults with cancer205. It 
includes 20 items testing a variety of cognitive functions, including memory, orientation, 
abstraction, and visuospatial ability. MMSE has low sensitivity to impairments in abstraction, 
executive function, and visual perception, and is highly dependent on good language function. 
 
The Geriatric Depression Scale (GDS).  The GDS was the first screening instrument for 
depression designed for use in older adults. The scale consists of 30 questions answered by 
yes or no. The sensitivity and specificity of GDS varies according to which cut-off is used for 
depression. A score of 14 or higher has been found to indicate depression with a sensitivity of 
80% and a specificity of 100%206. The GDS has well-established internal consistency, and 
high Cronbach’s alpha reliabilities have been reported, such as .94206 and .87207. Salamero and 
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colleagues have argued that the scale should be considered unidimensional207, while Adams 
and colleagues presented a five-factor measurement model estimated with confirmatory factor 
analysis methods that showed good overall fit using 26 items of the GDS208. The five factors 
were dysphoric mood factor, withdrawal/apathy/vigor, hopelessness, worry, and cognitive 
impairment208. In the current study, where GDS was considered unidimensional, the Cronbach 
alpha coefficient was .87 for the scale, suggesting good internal consistency reliability in our 
sample. In my experience, the GDS may be too intrusive in the pre-operative evaluation of 
cancer patients. Before initiating the study, we decided not to use a minimum GDS score for 
placement in the fit category in our categorization (see Table 2). Even if a GDS score of 14 or 
higher clearly indicates depression, there are no indications that a certain level of “happiness” 
is required to be classified as fit. In this respect we treated emotional status differently from 
for example comorbidity and nutritional status. 
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Categorization of patients into groups fit, intermediate, and frail based on the 
CGA 
The categorization of patients into the three fitness groups is thoroughly described in paper I. 
Table 2 displays the classification criteria for each group. 
 
Table 2. Categorization of patients based on CGA 
Tool Fit* Frail* 
 All of the following criteria One or more of the 
following criteria 
Barthel >18 <19 
NEADL >43  
CIRS Mild comorbidity Severe comorbidity 
No of drugs <5 >7 
MNA >23.5 <17 
MMSE >26 <24 
GDS  >13 
Abbreviations: CGA; comprehensive geriatric assessment, NEADL; 
Nottingham Extended Activities of Daily Living Scale, CIRS; 
cumulative illness rating scale, MNA; mini nutritional assessment, 
MMSE; mini mental state examination, GDS; geriatric depression 
scale 
*Patients who were neither fit nor frail were classified as intermediate 
 
 
Pre-operative assessment by the anesthesiologist  
American Society of Anesthesiologists Physical Classification System (ASA classification). 
Anesthesiologists routinely assign patients to an ASA category before surgery in Norway. 
ASA consists of the following six categories: 
1. A normal healthy patient 
2. A patient with mild systemic disease 
3. A patient with severe systemic disease 
4. A patient with severe systemic disease that is a constant threat to life 
5. A moribund patient who is not expected to survive without the operation 
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6. A declared brain-dead patient whose organs are being removed for donor purposes.  
The Norwegian Anesthesiology Society has published a Norwegian version on their webpage 
(http://www.nafweb.no/index.php?option=com_content&view=article&id=62:asa-
klassifikasjon&catid=38&Itemid=27, accessed Oct 26, 2010). In their translation, an age 
criterion has been added: A patient needs to be younger than 80 years to be assigned to ASA 
class 1. The ASA class was recorded from the hospital records. Data were missing in 16 
patients.  
 
Surgeon’s clinical judgment 
At Ullevaal University Hospital, we asked the surgeon who examined the patient the day 
before surgery to assign the patient to either one of the categories fit, intermediate, or frail 
based on their clinical judgment. This was recorded on a scoring sheet that was delivered to 
the principal investigator. The principal investigator did not discuss the patients with the 
surgeon, with a few exceptions that are noted under ethical considerations. 
 
Peri-operative routines 
Table 3 describes the peri-operative routines for elective colorectal cancer surgery at the three 
participating hospitals in the study. 
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Table 3. Peri-operative routines for elective colorectal resections at the three study hospitals 
Item Aker Ahus UUS 
Multidisciplinary team Surgeon, oncologist, 
radiologist, pathologist (not 
always) 
Same Same 
Oncological treatment Decided at UUS Same, a few patients also 
treated at Radiumhospitalet 
Decided at UUS 
Number of procedures (cancer) 
per year 
Colon 70       Rectum 30 Colon 120      Rectum 40 Colon 80      Rectum 50 
Standardized written pre-
admission information  
No No No 
Pre-operative bowel preparation Colon open surgery: No 
preparation                      
Colon laparoscopic: Oral 
preparation                      
Rectal surgery: Oral 
preparation 
Same Right colon surgery: No 
preparation 
Rectosigmoid surgery: Oral 
preparation 
Preoperative fasting Carbohydrate liquid until day 
of surgery 
Clear liquids until day of 
surgery 
Clear liquids until day of surgery 
Antimicrobial prophylaxis Doxylin 200 mg iv 
Metronidazole 1500 mg iv 
Doxycyclin 400 mg iv               
Metronidazol 1500 mg iv 
Doxycyclin 400 mg iv   
Metronidazol 1500 mg iv 
Use of edidural Yes, standard Same Same 
Nasogastric intubation Used during procedure, not 
routinely used post-
operatively 
Same Same 
Fluids post-operatively Patients can start drinking the 
day after surgery. Intravenous 
fluids, and in some cases 
nutritional supplement 
Same Patients start drinking at the day 
of surgery. Intravenous fluids, and 
in some cases nutritional 
supplement  
Urinary drainage Colon: Urethral catheter until 
epidural is removed       
Rectum: Urethral catheter 
until day 5 p.o. 
Colon: Same                             
Rectum: 3-5 days, follows the 
use of epidural, but in some 
cases 5 days is decided pre-
operatively 
Colon: Same                           
Rectum: 3-5 days, follows the use 
of epidural, but in some cases 5 
days is decided pre-operatively 
Prevention of post-operative ileus No specific measures Same Same 
Post-operative analgesia Epidural catheter, Paracetamol 
and opioids when necessary 
Same Same 
Post-operative nutrition Patients may try eating from 
day 1 
Same Patients encouraged to eat from 
day 1 
Post-operative mobilization Get out of bed and walk 
around day 1. Physiotherapy 
on demand 
Same Same 
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Post-operative complications 
Clavien’s morbidity grading system for post-operative complications: In this grading system, 
intended to be a standard reporting guide for morbidity, post-operative complications are 
broadly defined as “any event occurring within 30 days of surgery requiring treatment 
measures that are not routinely applied post-operatively for colorectal cancer”138. Post-
operative complications were classified according to severity. A grade I complication was a 
minor event that did not require treatment other than simple symptomatic drugs (for fever, 
pain or nausea). Lower urinary tract infection and urine retention were also included in this 
group. Another important criterion for a grade I complication was that it did not lead to a 
hospital stay “longer than twice the median stay for the procedure”. A grade II complication 
was a potentially life-threatening event, or an event that led to prolonged hospitalization 
beyond that of a grade I complication. Examples of grade II complications are pneumonia, 
wound infection requiring systemic antibiotics, and delirium. A further sub classification was 
based on intervention characteristics; grade IIa required only medical therapy, such as 
parenteral nutrition or blood transfusion, whereas grade IIb was resolved by invasive 
procedures. A grade III complication was also a potentially life-threatening event, further 
recognized by the development of lasting disability. Examples are myocardial infarction and 
cerebrovascular events leading to residual disability. Finally, a grade IV complication denoted 
the death of a patient due to a complication. The Clavien classification system has also been 
used in other studies of gastrointestinal surgery97,139. Because it is a highly comprehensive 
system, it is suitable for use in older patients, where even small events may lead to prolonged 
bedrest and functional decline. 
 
Paper I  
In this prospective observational cohort study, patients were assessed by a comprehensive 
geriatric assessment and subsequently categorized into three groups: fit, intermediate, or frail. 
The cut-off criteria for the three groups were defined apriori. In this paper, four patients were 
excluded from further analysis because they did not have complete data for a CGA-
categorization.  
 
After three months, 159 patients were available for analysis of living conditions. The patients 
who were alive (n=152) were interviewed by telephone, or responded by mail (n=6). The 
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telephone interview consisted of questions about whether the patient lived at home, and the 
The European Organisation of Research and Treatment of Cancer Quality of Life 
Questionnaire C-30 was filled out. However, the quality of life results have not yet been 
analyzed. The 19 patients who were not assessed did not respond by telephone or by mail 
about their living conditions.  
 
Paper II 
This paper describes 182 patients who were assessed pre-surgery. The tools are the same as 
for paper I, but no categorization of patients was performed. In this paper, the predictive 
ability of elements of CGA was compared to Eastern Cooperative Oncology Group 
performance status (ECOG PS).  
 
European Cooperative Oncology Group Performance Status (ECOG PS). This scale is used 
by oncologists to assess how the cancer disease affects the daily living abilities of the patient, 
how the disease is progressing, and to determine appropriate treatment and prognosis209. It is a 
scale based on five levels: 0; fully active, 1; restricted in physically strenuous activity but 
ambulatory and able to carry out work of light sedentary nature, 2; ambulatory and capable of 
all self-care, in bed less than 50% of the time, 3; capable of only limited self-care, in bed 
more than 50% of the time, 4; completely disabled, 100% bedridden. As surgeons in the three 
hospitals involved do not routinely use ECOG PS, the PI scored ECOG PS in our study. 
 
Paper III 
In addition to the CGA measurements, this paper included physical measurements such as 
grip-strength and gait speed, as well as an assessment of self-reported health; the European 
Organisation of Research and Treatment of Cancer Quality of Life Questionnaire C-30 
(EORTC QLQ C30).  
 
Modified physical phenotype of frailty measurements 
1) Grip strength 
Grip-strength. Grip strength was measured by a handheld Jamar dynamometer. The patients 
were asked to provide three tests with their dominant hand. The best score was recorded. Grip 
strength is one of the indicators in the physical phenotype of frailty. Cut-offs were calculated 
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from a cohort of more than 5000 community-dwelling individuals aged 65 years and older 
who participated in the Cardiovascular Health Study56. The lowest 20% according to gender 
and body mass index had a positive frailty criterion. 
 
2) Gait speed 
The Timed Up and Go (TUG) test. TUG measures, in seconds, the time taken by an individual 
to stand up from a chair, walk a distance of 3 meters, turn, walk back to the chair, and sit 
down again. We defined a time of 19 seconds or more as slowness, based on the time 
distributions in the Canadian Study of Health and Aging (CHSA)210. CHSA is one of the 
largest population-based studies to include the TUG. A cut-off of 19 seconds approximately 
identified the slowest quintile among the non-institutionalized participants in the CHSA. 
 
3) Low activity and exhaustion 
The European Organisation of Research and Treatment of Cancer Quality of Life 
Questionnaire C-30 (QLQ C30).  This core quality of life questionnaire is designed to 
measure cancer patients’ physical, psychological, and social functions211. The QLQ C30 is 
built by a modular approach to measuring quality of life, and it is composed of multi-item 
scales and single items. Five functional scales are incorporated: Physical, role, cognitive, 
emotional, and social, as well as three symptom scales: Fatigue, pain, and nausea and 
vomiting. In addition, there are two global health and quality of life scales. Furthermore, there 
are single items measuring symptoms such as dyspnea, appetite loss, sleep disturbance, 
constipation, and diarrhea, and there is a question about perceived financial impact of the 
disease and treatment. Most of the questions are answered on a scale from one to four, where 
three equals “quite a bit” and four equals “very much”. The QLQ C30 is a widely used 
measure of quality of life in cancer patients, and have been shown to exhibit satisfactory to 
excellent psychometric properties211. In our study, we have not yet analyzed the results of the 
quality of life data derived from QLQ C30. However, in order to operationalize a modified 
version of the physical phenotype of frailty from our dataset, we extracted three questions 
from QLQ C30. The original criteria for the physical phenotype of frailty proposed by Fried 
and colleagues used two extracted questions from the Center for Epidemiological Studies-
Depression scale questionnaire (CES-D Depression Scale) to categorize patients as frail by 
the exhaustion criterion56. In our dataset, if a patient scored three or four on either “have you 
felt weak?” (question 12) or “were you tired?” (question 18), they were considered to have a 
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positive frailty criterion for exhaustion. Both items are from the fatigue subscale of the QLQ 
C30. In order to categorize patients as frail by the low acitivity criterion in the study by Fried 
and colleagues, the authors used number of kilocalories of physical activity per week based 
on the short version of the Minnesota Leisure Time Activity questionnaire. In our study, 
patients were considered to have a positive frailty criterion for low activity if they reported 
“quite a bit” or “very much” when asked “do you need to stay in bed or a chair during the 
day” (question 4). This question is from the physical functioning scale of QLQ C30. 
 
4) Weight loss 
MNA includes a question about weight loss. If a patient reported a weight loss greater than 3 
kg during the last three months (screening question B from MNA), this was considered a 
positive weight loss criterion. 
 
Paper IV 
This paper utilizes all the CGA tools as well as the tools used in paper III. In addition, blood 
samples were analyzed. Blood samples were collected for routine pre-operative testing and 
additional blood was drawn for serum preparation, by centrifugation according to guidelines 
at the individual hospital laboratories (3400-3700 rpm for 10-12 minutes). The D-dimer 
analyses were performed at the respective hospital laboratories, with the STA Liatest® D-Di 
(Diagnostica Stago, Asnières, France). D-dimer was analyzed with the routine pre-operative 
blood samples. Serum was kept on ice during transport to be stored at -70° C. All the stored 
blood samples were analyzed at the same time in the laboratory at the Center for Clinical 
Heart Research, Ullevaal University Hospital. CRP levels were determined using an enzyme 
linked immunosorbent assay (DRG Instruments GmbH, Germany), detection limit 0.1 mg/L, 
coefficient of variation (CV) <5%. The remaining biomarkers were measured using enzyme-
linked immuno assays with commercially available kits (R&D Systems Europe, Abingdon, 
Oxon, UK): IGF-1 (CV (in our lab) 8%), IL-6 (CV 10.5%), TNF-a (CV 8,5%) and MCP-1 
(CV 9%).  
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Statistical considerations 
Variable characteristics  
Most of the variables in the study were categorized. The categories were decided apriori, 
based on the literature when available, or clinical experience (cut-offs for polypharmacy and 
IADL scores). Variables were either dichotomized or divided into three groups. For bivariate 
analyses, Chi-square-tests for trend or Pearson’s qui-square were used as appropriate. 
Outcome variables were either post-operative complications within 30 days of surgery, or 
survival. The post-operative complications were further divided into two separate outcomes: 
“any complication” versus “no complication”, and “severe complications” (grade II or higher 
according to the Clavien classification) versus “no/mild complications”. Logistic regression 
models were used for the dichotomized outcomes, while Cox regression models were used to 
investigate predictors of mortality.  
 
In paper III, the agreement between the two measures of frailty was tested with the Kappa 
Measure of Agreement. 
 
In paper IV, non-parametric methods were used due to skewed distribution of biomarkers. To 
examine differences in levels of the various biomarkers within each frailty-measure, the 
Kruskal-Wallis test was used. When overall significant differences (p<0.05) were found, we 
performed Mann-Whitney U tests between group pairs, adjusting the statistical level of 
significance to 2.5% using Bonferroni correction. We grouped levels of individual biomarkers 
into quartiles or tertiles, and examined their association to post-operative complications by 
chi-square tests. Trend analyses were performed to identify cut-off points. CRP-levels were 
dichotomized into values below the 25th percentile versus higher levels, and IL-6 in values 
below the 66.66th percentile versus higher levels. The dichotomized variables were 
subsequently included in crude and adjusted logistic regression models to examine their 
relative predictive value for post-operative complications.  
 
Challenges in the multivariate analyses 
The cut-offs of the variables influence the result of the multivariate analyses. We chose to 
adhere to our apriori defined categories when we analyzed the data in subsequent papers. In 
logistic regression analyses, the more variables you include in the model, the less power you 
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get in each test for significant effects on each variable. In addition to creating smaller 
subgroups within the dataset, logistic regression is also vulnerable to multicollinearity. To test 
for this in our multivariate models, we performed a linear regression analysis using the same 
outcome and predictors. There were no cases of tolerance values below .1 or Variance 
Inflation Factors values greater than 10, and this indicates that there are no multicollinearity 
issues in the data. ECOG PS and the three CGA categories were highly correlated, and could 
not be introduced into the same multivariable models. 
 
Missing values 
In clinical studies, one often has to deal with missing data. A few patients got tired during the 
CGA assessment, and we were not able to complete the assessment. In other cases, patients 
had to leave to complete pre-operative x-rays or speak to medical doctors involved in their 
cancer care. These data were considered as “missing” in the proper sense of the word, and we 
excluded such cases from all analyses. However, when variables with missing data became 
non-significant in the multivariate modeling, the whole cohort was included in the final 
calculations. There were no missing data for the outcome variables in the study. 
 
In the CGA categorization, patients who fulfilled at least one frailty criterion were assigned to 
this group even if they did not complete all the assessments, because one criterion was enough 
to place them in the frail category.  
 
For classification of the physical frailty phenotype the patients were required to have 
assessment data in at least three of the five domains. This was in accordance with the original 
publication by Fried and colleagues56.  
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Ethical considerations 
The Regional Committee for Medical and Health Research Ethics in East Norway as well as 
the Privacy Protection Representative at Ullevaal University Hospital approved the study. The 
inclusion in the study did not involve treatment leading to an increased risk of complications, 
and the comprehensive geriatric assessment did not have any consequences for treatment 
decisions. Extra blood was drawn, but only when it could be done in relation to the routinely 
performed pre-operative blood sampling. Ethical aspects included that the patients were 
subject to extra investigations that they may have found challenging, and that sensitive 
information was obtained and stored. Patients were in a sensitive phase, as they had only just 
learned about the cancer diagnosis. The inclusion was based on a written informed consent, 
and the patients were told that they might withdraw from the study at any time. The PI 
determined whether the patient was able to provide a written informed consent prior to the 
data collection. This was done by talking to the patient about their situation and describing the 
study. Patients who to the best of the PI’s knowledge seemed to understand the information 
were asked to sign the consent form. This decision was not changed even if the patient scored 
low on the MMSE later on. The data collection was terminated if the patient got tired or 
expressed distress when answering the questions, but this only happened on a few occasions.  
 
In two cases, the study provided crucial pre-operative information that would otherwise have 
been overseen. One patient with enlarged axillary glands on the preoperative CT scan 
(originally interpreted as metastases of the colon cancer) revealed during the CGA interview 
that she had been diagnosed with sarcoidosis many years earlier. The treating surgeon was 
informed. Another patient had extremely high values of D-dimer (analyzed solely for the 
purpose of the study) the day before surgery, and was found to have a lung embolus; surgery 
for the rectal cancer was subsequently postponed. On one occasion, the PI phoned the treating 
surgeon when a patient with myelodysplasia and low counts of neutrophil granulocytes 
experienced fever post-operatively. Three patients were referred to psychiatric follow-up due 
to high scores on GDS, and one patient was referred to a dietician because of malnutrition. 
Not all patients with depression or malnutrition were referred to follow-up, either because 
they already had received such care or because they preferred their primary physician to 
pursue these issues. 
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Main results 
This chapter describes the main results from the four papers briefly. More details are provided 
in the original papers. 
 
CGA as a predictor of post-operative complications 
and survival (papers I, II, and III) 
CGA predicted post-operative complications and survival in elderly patients electively 
operated for colorectal cancer. Increasing age and ASA score were not related to post-
operative complications. When the complete CGA was used as a basis for categorizing 
patients into three groups of fit, intermediate, and frail patients, the frail group had 
significantly higher rates of severe post-operative complications (OR 3.13, 95% CI 1.65 to 
5.92). When studying the occurrence of individual complications, frail patients had higher 
relative risks for developing pulmonary and cardiac complications as well as anastomotic 
leakage and delirium. The relative risks of readmission and reoperation were also 
significantly higher in the frail patients. Survival was also significantly reduced in frail 
patients compared to the non-frail, even when correcting for tumor stage. 
 
In paper II we omitted the categorizations and looked at the individual elements of CGA. We 
showed that severe comorbidity, dependency in IADL, depression, and malnutrition were the 
CGA-elements that independently predicted post-operative outcomes. However, when ECOG 
PS was added to the models, elements from CGA no longer contributed to the predictive 
model. The only exception was the presence of severe comorbidity; this CGA-element added 
to the predictive model of severe complications also after including ECOG PS. Severe 
comorbidity was also borderline significant as a predictor of survival along with ECOG PS. 
 
Frailty as a clinically useful predictor of post-
operative outcomes – comparing two approaches 
(paper III) 
This study of older adults with colorectal cancer demonstrated poor agreement between two 
definitions of frailty – one based on multi-dimensional geriatric assessment criteria and the 
other based on the physical phenotype of frailty criteria (PF). The two classifications were 
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quite consistent in terms of the cases classified as non-frail; however, there was inconsistency 
between the cases each method considered frail. Interestingly, only one of the frailty 
classifications was able to predict post-operative complications. The use of a frailty measure 
as a result of CGA was a much better predictor of 30-day morbidity than the modified 
physical frailty phenotype. The frailty identified by the physical frailty phenotype was neither 
a significant predictor of any post-operative complication nor of the severity of complications, 
whereas the CGA-based frailty measure predicted post-operative complications as well as 
severe complications. Both frailty classifications were predictive of overall survival. It seems 
that excluding comorbidity from the physical phenotype of frailty makes this classification 
less useful as a predictor of short-term outcomes.  
 
Pre-operative levels of biomarkers in elderly patients 
with cancer and their relation to frailty status (paper 
IV) 
When comparing levels of biomarkers between patients classified according to a modified 
version of the physical frailty phenotype and a CGA, we found overall differences in levels of 
CRP, IL-6, TNF-α and D-dimer: levels of all these markers were significantly higher in frail 
patients within both measures. IL-6 remained an independent predictor of severe post-
operative complications even after adjusting for frailty-status.  
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Discussion 
Decision making in elderly patients 
Treatment decisions in older adults with colorectal cancer are not based solely on the surgical 
risk. Colorectal cancer is a deadly disease. Furthermore, the tumor itself represents a threat to 
the patient’s health, functional status, and quality of life. For example, the tumor may cause 
obstruction, bleeding, distant metastases, or local invasion, resulting in medical emergency, 
pain, suffering, fatigue, or discomfort. Thus, removal of the tumor is often indicated, even in 
advanced age. However, for patients with a stage IV colorectal cancer, surgical removal of the 
primary tumor is controversial. According to guidelines from the National Comprehensive 
Cancer Network in the US, surgery is indicated if the patient is symptomatic, at risk of 
impeding obstruction, or has metastatic sites possibly open to curative resection96. In a US 
study of patients ≥ 65 years with stage IV disease, 72% underwent surgery96. Epidemiological 
data show a high resection rate of colon cancer in elderly patients2, while data from the 
Norwegian Rectal Cancer Project demonstrate that surgical treatment of rectal cancer 
becomes less common with increasing age188. In a Norwegian study of colorectal cancer in 
patients over 80 years from 1998, the resectability rate for patients < 80 years was 93% and 
the rate of curative resection was 75%, while in patients aged 80 and over the corresponding 
rates were 81% and 59%212. All treatment decisions are based on an evaluation of risks versus 
benefits. In older adults, this is often less straightforward than in younger people. An 
important first step is to determine remaining life expectancy, which again depends on 
chronological age, comorbidity, and functional status9. There may be “competing risks”; a 
scenario where the patient has two or more diseases that are life-threatening23. The next step 
would be to evaluate whether the disease may influence the patients’ health, functional level, 
and/or quality of life within his or her remaining lifetime. A small intestinal tumor that 
constantly bleeds and causes anemia, may dramatically limit functional status and well-being. 
A large tumor that may cause obstruction increases the risk of emergency surgery. Emergency 
surgery carries a much higher risk than elective surgery, and this is even more pronounced in 
the elderly. These factors necessitate thorough information to the patient; the risks of surgery 
on one hand, compared to the risk of not having surgery on the other hand. Experiences from 
clinical work sometimes leave the impression that health personnel without special 
knowledge of oncology want to “protect” the older adult from what they conceive as “harmful 
treatment”, such as surgery, without knowledge of the risks of not being operated. It has been 
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documented that both caregivers and health professionals actually under-estimate the older 
patient's willingness to undergo treatment213. It has also been shown that older adults accept 
chemotherapy treatment in a similar fashion than younger patients214. However, in the same 
study, the older patients were less willing to trade survival for current quality of life when 
treatment was presumed. 
 
Pre-operative risk assessment – scales versus 
clinical judgment 
There are several ways to measure pre-operative risk. In Norway, anesthesiologists routinely 
assign patients to an ASA class pre-operatively. More specific risk models such as POSSUM 
and APACHE II have been developed, as discussed previously. In our cohort, we found that a 
classification based on CGA predicted the occurrence of post-operative complications, 
whereas increasing age and ASA classification did not. The vast majority of our patients were 
classified as ASA II or III, and the two categories were not able to differentiate between 
patients who experienced complications and patients who did not. The multivariate analyses 
of CGA-elements identified severe comorbidity, IADL-dependency, and depression as 
independent predictors of morbidity. Table 4 displays a comparison between a categorization 
based on CGA (into fit, intermediate, or frail) and the model derived from the multivariate 
analysis of elements of CGA and their ability to predict severe complications.  
 
Table 4. Comparison of CGA categorization and elements of CGA for prediction of 
severe complications 
 PAC Sensitivity Specificity PPV NPV 
CGA 
categorization 
66.3% 77.1% 56.8% 61% 74% 
Elements of 
CGA 
66.5% 53.6% 77.6% 66% 68% 
Abbreviations: CGA; comprehensive geriatric assessment, PAC; percentage accuracy in 
classification; PPV; positive predictive value, NPV; negative predictive value 
 
 
After a stepwise backward logistic regression analysis with elements of CGA, the percentage 
accuracy in classification of severe complications was 66.5%. The sensitivity was 53.6%, 
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while the specificity was 77.6%. The positive predictive value (the percentage of cases 
predicted by the model to have severe complications that was actually observed to have 
severe complications) was 66%, while the negative predictive value was 68%. When using 
the categorization based on a complete CGA in the multivariate analyses, the percentage 
accuracy in classification was 66.3%. The sensitivity was 77.1%, while the specificity was 
56.8%. The positive predictive value was 61%, while the negative predictive value was 74%. 
These data are derived from the classification tables of the multivariate analyses.  
 
Interestingly, our data indicate that the surgeon’s judgment can predict morbidity in a manner 
comparable to a CGA-classification. We asked the surgeons at Ullevaal University Hospital 
to report whether they considered the patient to be fit, intermediate or frail after they did their 
pre-operative assessment. The reason why we did this was because we expected CGA to be a 
much better predictor. Given that the surgeons evaluated only 49 of the 182 patients, this 
dataset is less robust. Surgeons’ judgment turned out to be a good predictor of severe 
complications. The overall percentage accuracy in classification for the surgeons’ judgment 
was 72%, sensitivity was 65.2%, and specificity was 77.8%. Positive predictive value of the 
surgeons’ judgment was 71%. When CGA classification was used in the same patient sample, 
the overall accuracy in classification was 69.4%, sensitivity was 65.2%, and specificity was 
73.1%. The positive predictive value was 68%. Of the 29 patients that were classified as “fit” 
by the surgeons, 15 were intermediate and 8 were frail according to CGA. Only 6 patients 
were classified as fit by both the surgeons and the CGA assessment. A comparison between 
the two classifications is displayed in Table 5. 
 
Table 5. Crosstabulation of CGA category and surgeons’ judgment 
Surgeons’ judgment  
Fit Intermediate Frail 
Total 
6 0 0 6 
15 6 0 21 
8 9 5 22 
CGA category    Fit 
                            Intermediate 
                            Frail 
Total 29 15 5 49 
 
This observation needs validation in a separate cohort, but may have practical implications. 
Other authors have found that clinical judgment is a valuable predictor of risk, and in some 
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cases even superior to standardized scoring tools. For example, Mary Charlson found that the 
residents’ scoring of disease severity was a more accurate predictor of mortality than the 
Charlson comorbidity index215. Furthermore, Christensen et al found that perceived age 
predicts survival among people aged 70 and older, even after adjustment for chronological 
age, sex, and other biomarkers of aging216. In that paper, the authors ask why there has been 
so little research on the reliability and validity of perceived age given that it is so widely used 
and formally registered in patients’ notes in many settings. It may be that perceived age, and 
the use of clinical judgment, is deemed as less scientific because of their diffuse and 
subjective nature. However, in my opinion, the sensitivity and specificity of short screening 
tools should be tested against clinical judgment – to investigate whether the formal tools add 
predictive value. Within geriatric oncology, for example, a number of short screening tools 
have been proposed in order to identify patients who will benefit from a complete CGA217. 
However, it may be that the judgment of the surgeons or oncologists is equally sensitive if 
they are asked to consider the need for a CGA. This conception is often met with reluctance 
and even anger, because it is interpreted as a step backwards for geriatric oncology, leaving 
patients with the rule of thumb approach instead of evidence-based medicine. In my opinion, 
this is a misunderstanding that probably reflects the misconception of judgment as an 
unscientific approach. My own experience with this clinical research study has made me 
aware of some of the limitations of a purely quantitative approach. It is likely that the 
development and use of a screening tool is not as straightforward as it seems, considering all 
the choices that have to be made along the way to develop the tool, for example regarding 
scoring, cut-off values, which items to include, and what outcome measures to study. 
Furthermore, the systems for scoring are fixed, and in practical medicine there will often be 
surrounding factors that make the sum score seem misleading. As an argument opposing the 
usefulness of judgment as a predictor of risk, a study from British Journal of Urology found 
that doctors (urologists and oncologists) were poor at predicting 10-year survival when 
presented with patient case scenarios218. The authors conclude that many patients may be 
denied treatment after a (wrongly) pessimistic assessment of life expectancy. An important 
limitation with that study, however, is that the doctors did not meet the patients. The value of 
clinical judgment does not only lie in the facts about the patients, but according to 
Christensen’s results it is more likely to be based on the actual perception of the patient. This 
detail has important implications, as “paper representations” of real patients are frequently 
used in multidisciplinary meetings where treatment plans are formed. In conclusion, including 
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judgment as an addition to established assessment tools is more likely to contribute to science 
than to undermine it.  
 
It has been shown that CGA adds information to ECOG PS in older adults with cancer 81, and 
it is frequently stated that ECOG PS is not sufficient as an assessment of fitness in the elderly. 
In our study, ECOG PS turned out to be an independent predictor of all outcomes. When 
estimating pre-operative risk in our patients, ECOG PS alone certainly provided valuable 
information. For some reason, assessment of functional status as a part of the pre-operative 
evaluation of elderly patients is not a well-established practice, and as discussed earlier the 
majority of surgical publications lack information about functional status. The publications 
that do include measurements of function or performance status frequently find this factor to 
be an independent predictor of risk71,97,114,219-221. We found that ECOG PS was a more useful 
measurement of functional status than ADL and IADL for pre-operative risk assessment. In 
PACE, however, IADL was a stronger predictor than ECOG PS for morbidity122. PACE also 
included a measurement of fatigue in the model, and this could be part of the explanation for 
the difference in results.  
 
Surprisingly, there were no significant differences in morbidity between the fit and 
intermediate groups in our study. The criteria for being classified as fit were very strict, and 
the fit group was the group with the smallest number of patients (n=21). One explanation for 
the lack of differences in morbidity may be that the number of patients was too small to yield 
any statistical significance.  Another possibility is that patients defined as frail were above 
some threshold that made them susceptible to complications, while the fit and intermediate 
both were below this threshold. However, we cannot pinpoint this threshold from our dataset 
or the design of the study. 
 
The frail group in our study was mixed, as patients may have had one or more frailty criteria. 
Forty-one patients were frail because of severe comorbidity, out of a total of 76 frail patients, 
and severe comorbidity was the most frequently occurring frailty criterion. Of the 76 frail 
patients, there were 43 patients (57%) fulfilling one frailty criterion, 22 patients (29%) 
fulfilling two frailty criteria, eight patients fulfilling three frailty criteria, one patient fulfilling 
four frailty criteria and two patients fulfilling five frailty criteria. We have not made subgroup 
analysis within the frail group. 
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Advantages of CGA 
Even though we found that quicker assessments, such as the surgeon’s judgment and ECOG 
PS, were comparable to a CGA-assessment in pre-operative risk prediction, there are several 
arguments favoring completing CGA as a pre-operative assessment in older adults. Firstly, 
CGA may uncover previously unknown medical problems, such as cognitive dysfunction and 
depression. Secondly, knowledge about social support, ADL-function, and cognition may 
provide information about adherence to treatment protocol. In some cases, arrangements must 
be made regarding transportation and emergency contacts. The same type of information is 
important for adequate discharge planning. I will briefly go through the elements of CGA and 
their potential contributions to patient management in this setting. 
 
Physical functioning 
In our study, requiring assistance in IADL was an independent predictor of experiencing any 
post-operative complication. In addition, knowledge of pre-operative functional limitations 
may improve the discharge planning as it can be tailored to specific needs. In order to 
establish a patient-focused goal for rehabilitation after surgery, which aims to restore 
functional ability of the patient, knowledge of the functional status prior to the surgical 
procedure is required. 
 
Comorbidity 
Not surprisingly, severe comorbidity was predictive of post-operative complications and 
survival in our cohort. Assessment of comorbidity is already one of the most important parts 
of the pre-operative evaluation of patients. Whether the use of designated comorbidity 
indexes adds to assessing specific comorbidities in the pre-operative setting remains 
uncertain, and comorbidity indexes are rarely used in clinical practice. However, if measuring 
the total burden of comorbidity adds information regarding remaining life expectancy, and 
provides an estimate of physiologic reserves, it may be relevant for decision-making. The 
cumulative illness rating scale also provides data for comorbidity in individual organ systems, 
and these data will be explored at a later time. 
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Polypharmacy 
In our cohort, 26% of the patients used five or more drugs. A thorough assessment of the 
patient’s medication list before surgery is important. There may be unnecessary or duplicate 
drugs, drug interactions, or drugs that carry a high risk of side effects. In addition, the list of 
medications may alert the surgeon about comorbidities that were not noted in the medical 
records. We did not find polypharmacy, defined as number of systemic drugs in daily use, to 
be predictive of any outcomes in our study. However, there was a trend towards more 
frequently occurring severe post-operative complications in the patients who used five or 
more drugs (OR 1.73, CI 0.87 to 3.44). Polypharmacy is closely related to comorbidity, and 
comorbidity appears to be a more sensitive predictor of surgical risk. 
 
Nutritional status 
Even though it is frequently seen among elderly hospitalized patients, malnutrition often goes 
undiagnosed222. In patients undergoing gastrointestinal surgery, the reported prevalence of 
malnutrition is up to 50%135. Studies have found that nutritional risk is associated with 
increased post-operative morbidity and mortality, but these studies have been carried out in 
younger and mixed populations, and the analyses are not corrected for functional status 
135,223,224. Furthermore, the tools used for nutritional screening varied among the studies. We 
found that the 9% of our patients that were malnourished tended to have a higher risk of 
severe complications and any complication (OR 2.77, 95% CI 0.89 to 8.65, and OR 2.49, 95% 
CI 0.77 to 8.06, respectively). We did not analyze whether malnutrition predicted individual 
complications. Interestingly, in the survival analyses, having a normal nutritional status as 
opposed to being at risk for malnutrition or malnourished was associated with better survival 
(hazard ratio 2.39, 95% CI 1.24 to 4.61). One could speculate that a normal nutritional status 
is a marker of less frailty, as we found that both frailty measures calculated in our study 
predicted overall survival. Nutritional status represents an interesting pre-operative risk factor 
because it is potentially reversible.  
 
Cognitive dysfunction 
The need for a pre-operative cognitive assessment in elderly patients undergoing surgery can 
hardly be disputed. The prevalence of cognitive dysfunction increases with age, and in some 
cases cognitive dysfunction is undiagnosed. This may easily go unnoticed in a brief pre-
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operative counseling if formal cognitive testing is not carried out. Cognitive problems 
necessitate adjustments of the pre-operative counseling, have implications for choice of 
treatment, and increases the risk of post-operative delirium, which may be prevented47. Even 
though cognitive dysfunction was not predictive of morbidity in our study, cognitive 
dysfunction was significantly associated with post-operative delirium (p<0.001, test for 
trend). Furthermore, the use of a more sensitive measure of cognitive function than MMSE 
might have given different results.  
 
Depression 
There are studies indicating that emotional factors, such as depression, are strongly predictive 
of surgical outcomes such as functional recovery and pain225. The mechanisms remain 
unclear. There may be biological explanations involving the immune system, and a behavioral 
component such as less interest in post-operative mobilization cannot be entirely ruled out. 
Treatment of depression pre-operatively might be beneficial, but to our knowledge no 
scientific evidence support this. Unresolved questions are: What type of treatment, which 
antidepressant drugs, will the benefit outweigh the increased risk of postponing surgery? In 
any case, a positive screening for depression pre-operatively should alert the surgeon to 
arrange for follow-up either in-hospital or after the patient is discharged. Being depressed was 
significantly associated with experiencing post-operative delirium in our data (p=0.01, 
Fisher’s exact test). 
 
Feasibility in clinical practice 
An important question that arises when presenting surgeons with the idea of doing a pre-
operative CGA is “how long does it take?”. In a hectic clinical practice it is not possible for 
the surgeon to spend one hour with each elderly patient. A lot of effort has been put into 
developing screening tools for frailty in order to identify patients in need of a full CGA. 
Unfortunately, this has been done even though the scientific rationale for CGA is still 
uncertain. Furthermore, the screening tools that are tested have not been compared to clinical 
judgment. Practical considerations are important, however, time restrictions, as a sole 
argument against doing a thorough pre-operative work-up, may not be valid. A frail older 
adult with colorectal cancer scheduled for surgery may in many cases have functional 
limitations, several comorbidities, a long list of medications, and cognitive problems. 
71 
 
Spending only 10-20 minutes on a pre-operative evaluation of this patient makes little sense 
from a clinical point of view. Furthermore, a hastily performed pre-operative evaluation might 
actually lead to extra work post-operatively, such as complications that could have been 
avoided (for example delirium), uncontrolled comorbidities, unforeseen problems with 
rehabilitation and problems when discharging the patient to his home. We found that frail 
patients had significantly higher rates of readmissions and a longer length of stay, and we 
hypothesize that a more extensive pre-operative work-up would save time after surgery. This 
needs to be tested in a randomized controlled trial in frail patients. The enhanced recovery 
after surgery program, which involves careful peri-operative planning, has already been 
consistently shown to reduce morbidity, lead to a faster recovery, and shorten hospital 
stays140. 
 
Frailty  
In the context of cancer treatment such as chemotherapy and surgery, it is pertinent to be able 
to identify patients with limited reserve capacity. In theory, such treatment will potentially 
exhaust the patient’s reserves and lead to complications and toxicity. If these complications 
are worse than the cancer disease or even fatal, the treatment was not justified. As mentioned 
earlier, even though the term frailty is frequently used among health professionals, there is 
still no universally accepted method to identifying frailty. The multi-domain CGA-based 
definition in our study identified a group of patients with higher risk of complications, and 
this definition was more useful than the modified version of the physical phenotype of frailty 
that disregards comorbidity. Traditionally, within gerontology and geriatrics, natural age-
dependent changes in structure or function of organs have been distinguished from age-related 
pathologies. However, normal age-dependent changes are believed to be associated with the 
prevalence of age-related pathologies, and diseases in organs along with the aging process 
will exert synergistic effects on each other. The same is probably true for comorbidity and 
frailty. Maybe the distinction between frailty and comorbidity is less useful from a practical 
point of view? A recent surgical study showed that the frailty indicators used in the physical 
phenotype of frailty are predictive of post-operative complications226. Interestingly, the 
standardized definition of frailty (three or more criteria) was not utilized in that study. Instead 
of using a prior hypothesis for their regression analysis, the authors explored the dataset to 
find the most optimal cut-off for frailty. They divided the cohort into three new groups, and 
patients with 0-1 indicators were classified as non-frail, patients with 2-3 indicators were 
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classified as intermediately frail, and patients with 4-5 indicators were classified as frail. For 
this reason, the results of this study cannot be directly compared to the results from our study 
or to other studies that use the established definition of the physical phenotype of frailty. 
 
The correlation between biomarkers of inflammation and coagulation and frailty measures 
may have some practical consequences. Biochemical markers that increase the validity of 
clinical assessments are attractive for several reasons: they are objective, easy to obtain, and 
may be compared across large samples. Furthermore, biomarkers provide a possible link to 
the pathophysiological process and etiology. Additional data are needed to establish the role 
of biomarkers in identifying frailty, but our findings support previous findings suggesting an 
important role of inflammatory pathways66,67. Even though different patients were classified 
as frail according to the two measurements, the levels of CRP and IL-6 were consistently 
increased in both models. The same holds true for D-dimer, suggesting that activation of 
coagulatory pathways may contribute to frailty.  
 
Choice of cut-offs and tools in the study  
In this prospective study, the cut-offs for the various elements of CGA were established 
apriori. As described under methods, the choices were based on the literature where available, 
or by common practice in Norway. Thus, we did not use exploratory statistics to determine 
cut-off values. In multivariable analyses, the choice of cut-offs heavily influences the results 
of the analyses. This is best illustrated by looking at the cumulative illness rating scale 
(CIRS). As CIRS scores 14 organ systems on a range from 0-4, various scores are obtained: 
- total score 
- number of categories with disease (score 1-4) 
- number of categories with score 2-4 
- number of categories with score 3 
- number of categories with score 4  
- severity index (total score divided by number of categories with score 1-4) 
 
Furthermore, one may group the patients into no/mild comorbidity, intermediate comorbidity, 
and severe comorbidity based on number of categories with score 2, 3, and 4. This is the 
approach we used in our study. The total score of CIRS is somewhat unreliable, because the 
results are easily influenced even if the scorer misses small complaints such as constipation, 
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mildly reduced hearing, or mild depression. Comorbidities grades 3 or 4 are unlikely to be 
ignored, making these scores a more robust finding. It is important to decide which scores 
from CIRS to use before analyzing the data, because the high number of possible 
combinations may facilitate statistical manipulation. As mentioned above, I think it was 
unwise to change the criteria for frailty according to the physical phenotype in the study by 
Makary and colleagues226. Instead of using an established definition, they explored the dataset 
to find the best cut-off. Thus, their analysis is data-driven rather than hypothesis-driven. This 
is a problem when the criteria for a categorization have already been established, because it 
makes it difficult to compare results across different studies. 
 
Methodological differences make it difficult to compare the results from our study to similar 
studies. In Preoperative Assessment of Cancer in the Elderly (PACE), for example, 
comorbidity was not found to predict post-operative morbidity122. Audisio and colleagues 
used Satariano’s index of comorbidities134. This index was validated in a cohort of women 
with breast cancer, where it predicted mortality, but of whom only a small percentage was 
older than 70 years. The index disregards dementia and stroke, while gall bladder disease 
yields a high score.  Thus, in my opinion, this index is less useful for elderly cancer patients, 
and the choice of index may have influenced the multivariate results from PACE. The use of 
shorter versions of the CGA tools may also influence the outcome from studies. In PACE, 
GDS-15 was used instead of GDS-30. The cut-off for depression was set to 4, and they found 
that 27% of the patients were depressed. This cut-off cannot be directly compared to our cut-
off of 14 (we found that 11% of the patients were depressed). In conclusion, when there are 
several ways to study the data, establishing cut-offs apriori is of paramount importance to 
ensure that results are based on a prior hypothesis, and not due to extensive search in the data. 
Furthermore, comparison between studies remains difficult when tools and cut-offs are not 
standardized. In order to make progress within the field of geriatric oncology, a standardized 
geriatric assessment tool is highly desirable. This would make it possible to compare 
treatment outcomes and pool results from studies across different populations. 
 
Relevance of peri-operative care in the interpretation of our results 
The main focus of our project was to study the association between elements from a geriatric 
assessment and risk of post-operative complications and survival in elderly patients operated 
for colorectal cancer. We did not design this study to investigate peri-operative care of 
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colorectal cancer patients. As peri-operative care issues influences post-operative morbidity, 
as extensively discussed in the introduction of this dissertation, the question remains whether 
differences in peri-operative care may have influenced the results of our study. In order to test 
the hypothesis that a pre-operative CGA-based categorization of older cancer patients could 
predict post-operative complications, we chose colorectal cancer patients with the assumption 
that this patient cohort was relatively homogeneous (as opposed to investigating all types of 
cancer surgery) with a relatively standardized procedure. Studying the influence of peri-
operative routines was not the scope of the study, as our focus was to study the role of a 
geriatric assessment and frailty in older patients with colorectal cancer. We assumed that the 
peri-operative routines were fairly similar in each individual patient and in the three hospitals, 
and that they would not confound the results in any systematic way. 
 
The treatment of colorectal cancer is fairly standardized in Norway through national 
guidelines published and updated regularly by the Norwegian Gastrointestinal Cancer Group 
since the early 1990s. The guidelines were accessible from a book (“Grønnboka”), and later 
through the organization’s website (www.ngicg.no). Since 1993, when the National Rectal 
Cancer Registry was established, regular meetings in a reference group with members from 
many hospitals have contributed to discussion and dissemination of the recommendations. 
The pre-operative investigations, surgical methods, the use of (neo-)adjuvant treatment and 
follow-up after curative surgery have therefore been standardized in Norway for many years, 
and the guidelines are followed in most hospitals. 
 
However, until 2010 there were no guidelines with regards to the principles of peri-operative 
care presented on pages 31-41. We took steps to minimize institutional differences in peri-
operative care, as we chose three University Hospitals in Southern Norway with comparable 
case-load and surgical experience. When comparing the peri-operative routines at the three 
hospitals in our study, the differences are small (Table 3). Although peri-operative factors are 
interesting from a practical surgical point of view, it is likely that the three hospitals in our 
study have a relatively uniform approach to the surgical treatment and peri-operative care of 
colorectal cancer patients. Furthermore, the design of this study does not allow for 
conclusions about the effect of differences in peri-operative care, and is merely hypothesis 
generating as observational studies always are. Analyses of differences in complication rates 
between the hospitals also support our approach: Chi-square tests reveal no differences in rate 
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of complications between the three hospitals (p=0.97). The same holds true if the model 
includes tumor location (Aker university hospital had a higher rate of rectal cancer surgery), 
type of surgery (Ullevål university hospital had a higher rate of laparoscopic surgery), or 
fitness level of the patients. Finally, as all the hospitals have established routines for treating 
colorectal cancer, it is highly unlikely that systematic treatment differences between the three 
patient categories have influenced the main findings in our study. On the contrary, all the 
patient in this study were older than 70 years old, creating a unique homogeneous cohort of 
prospectively studied older adults undergoing this type of surgery. 
 
As discussed in the papers, rectal cancer surgery was associated with a higher rate of 
complications than colon cancer surgery, entirely in line with the literature. Laparoscopic 
surgery was associated with a lower number of complications in univariate analyses, but 
remained insignificant in multivariate models. In a separate analysis, where only colon 
cancers were included, laparoscopic surgery was not associated with a lower number of 
complications (p=0.3), illustrating that tumor location was a more powerful predictor than 
type of surgery. 
 
Comparable studies, such as PACE, have looked at the association between CGA-elements 
and all types of cancer surgery in a joint analysis122. In a large study by Alves and 
colleagues189, studying risk factors associated with post-operative mortality and morbidity 
after colorectal resections in 1421 patients, the following two variables related to peri-
operative care were univariately associated with post-operative mortality (among a total of 28 
variables): no prophylactic antibiotics and no bowel preparation. In comparison, seven pre-
operative patients variables (age, BMI, ASA class, underweight, Glascow Coma Scale score, 
cardiopulmonary comorbidity, neurologic comorbidity) were univariately associated with the 
outcome. After multivariable analyses, both of the variables related to peri-operative care 
were removed from the model, suggesting that these factors were not relevant for predicting 
post-operative mortality in colorectal resections in this large cohort. For predicting post-
operative morbidity, the only factor related to peri-operative care that was significant in 
univariate analyses was no bowel preparation, and again, this variable disappeared in 
multivariable analyses, suggesting little impact of such factors in predicting post-operative 
morbidity after colorectal resections. In contrast, age, cardiopulmonary comorbidity, and 
neurologic comorbidity retained significance in the multivariate model, thus highlighting the 
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importance of pre-operative patient factors when constructing models to predict risk of post-
operative morbidity.  
 
Practical consequences 
The results of our project highlight the need for an individualized assessment of elderly 
patients prior to surgery for colorectal cancer. Increasing age itself does not appear to increase 
the surgical risk in elective procedures, at least not in our cohort. Furthermore, the established 
ASA classification was not sensitive enough to predict outcome in our patient group. The 
results need to be validated in a different sample of patients. Whether or not CGA-based 
interventions in frail patients may reduce complication rates need to be tested in a randomized 
trial. In Norway, there are not sufficient geriatricians to take part in the routinely performed 
pre-operative assessment of elderly cancer patients. Surgeons are used to operating the 
elderly, but specific training in geriatric medicine for surgeons is to my knowledge not well 
established. Such training would be useful in order to improve the surgeons’ knowledge about 
functional status, cognitive function, and clinical aspects of geriatrics such as the occurrence 
of general symptoms instead of organ-related symptoms, atypical presentations of disease, 
and geriatric syndromes. Assessment of functional status, nutrition, emotional status, and 
formal testing of cognitive function could all be done by a nurse prior to the pre-operative 
counseling. However, surgeons would need to know how to interpret the results of such 
assessments in order to make them useful. 
 
Weaknesses of the study 
One of the main weaknesses of the study is that we did not manage to include all the patients 
that were scheduled for surgery at the three hospitals during the inclusion period. As the PI 
did all the assessments, patients were lost when the PI was not available. This happened 
during PhD courses or vacation. Furthermore, not all patients were reported to the PI from the 
respective hospitals. In some cases the surgical schedule was changed in the last minute, and 
patients were already operated when the PI came to assess them. All in all, the patients were 
lost in a random manner, and it is unlikely that the results are affected in a systematic way. 
The number of patients that were missed was calculated by counting the number of patients 
70 years or older scheduled for elective surgery from the surgical programs at the three 
hospitals in a retrospective manner. As these patients were not included in the study, and thus 
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had not signed any consent forms, no information was recorded about these patients. For this 
reason, we cannot calculate whether or not they were different from the patients who were 
included in our study. In conclusion, we cannot be entirely sure that our sample is 
representative for all patients operated at the three hospitals in the designated time, but due to 
the arguments presented above it is not unlikely that patients were missed in a random 
manner. 
 
The 19 patients who did not respond by telephone or mail about their living conditions after 
three months were characterized by a higher number of patients categorized as frail (63% 
versus 40%), slightly more women (63% versus 57%), and a mean age comparable to the rest 
of the cohort (81 years compared to 80 years). The only data used from the follow-up at three 
months were data regarding living conditions, and it is likely that the actual numbers of 
patients needing nursing home or extended care are slightly under-estimated in paper 1.  
 
The interventions that were carried out for ethical reasons may have had a minor impact on 
overall survival. 
 
The PI who did the CGA-assessments also did the scoring of ECOG PS, and this may have 
influenced the results in paper II. An oncologist who has limited time with the patient usually 
scores ECOG PS, and thus the basis for scoring ECOG PS was much broader in our study 
than in routine clinical practice.  
 
For the comparisons of the frailty measures, an important weakness was that the physical 
phenotype of frailty was not measured in the exact same way as in the original publication by 
Fried and colleagues. However, for subjective measurements such as exhaustion and low 
activity, we believe that the results are comparable, because the questions from QLQ C30 are 
quite similar to the described measurements in the original study. Exhaustion was originally 
based on two questions extracted from the CES-D Depression Scale (“I felt everything I did 
was an effort” and “I could not get going”). Subjects answering “a moderate amount of the 
time” or “most of the time” on either of these questions were categorized as frail by the 
exhaustion criterion. For low activity, the criterion in the original PF definition was based on 
self-reported low activity from the Minnesota Leisure Time Activity questionnaire. We did 
not have such a measurement. In a paper by Rockwood and colleagues210, two approaches to 
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measuring frailty were compared in a similar fashion. In that paper, low activity was 
operationalized as needing assistance with walking or being unable to walk. In our study, 
patients were considered to have a positive frailty criterion for low activity if they reported 
“quite a bit” or “very much” when asked “do you need to stay in bed or a chair during the 
day”, because needing to stay in bed or a chair for a lot of the time during daytime implies 
low activity. The question was from the physical functioning scale of QLQ C30. For this 
reason, even though we find that our results are most likely comparable to the other studies, 
our results must be interpreted with caution. Our classification is in any case an 
approximation to measuring frailty as clusters of physical impairments, even though there 
may be some deviations from the original physical phenotypic frailty criteria. Furthermore, 
the QLQ C30 was not designed to measure exhaustion and low activity by extracting 
questions from the subscales. We plan to analyze the results from QLQ C30 before surgery, 
after three months, and at 1-2 year follow-up at a later time, and in order to proceed with 
those analyses the internal validity of the QLQ C30 questionnaires will need further 
investigation.  
 
As previously mentioned in the published papers, a weakness regarding recording of post-
operative complications was that the information was collected retrospectively. The major 
sources for these data were medical records. The following complementary approach was 
used to ensure comprehensive information about morbidity: data were extracted from all 
available medical records; including charts, doctors’ notes (inpatient and outpatient), nurses’ 
notes, and discharge papers. In uncertain cases the medical team was consulted, and if there 
were inconsistencies in the records nursing homes, caregivers, or patients were consulted. 
Especially for the occurrence of wound infections, it is important to follow the patients after 
discharge to ensure complete morbidity data: in a study by Weigelt and colleagues, 35% of 
surgical wound infections first became manifest after discharge227. Thus, even though 
registering post-operative complications retrospectively certainly is a limitation of our study, 
and the optimal approach would have been a prospective registration, it may be argued that 
we took several steps to minimize the impact of this limitation. In any case, post-operative 
complications were registered in the same way for all the patients, and the significant 
differences in complication rates between frail and non-frail patients remain an interesting 
finding. 
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Conclusions 
- Elderly patients (70 years old and older) electively operated for colorectal cancer 
experienced a high rate of post-operative complications, but the operative mortality 
rate was low  
- A comprehensive geriatric assessment (CGA) identified a subgroup of frail elderly 
patients who experienced a significantly higher rate of post-operative complications 
compared to patients who were non-frail 
- Increasing age and ASA class were not predictors of complications in this cohort 
- Survival in elderly patients operated for colorectal cancer is influenced by cancer stage 
and frailty status 
- The most important CGA-elements associated with post-operative complications and 
survival were dependency in instrumental activities of daily living, severe 
comorbidity, impaired nutrition, and depression 
- Eastern Cooperative Oncology Group performance status can predict post-operative 
complications and survival  
- Surgical publications about pre-operative assessment in the elderly should include 
measurements of physical performance and comorbidity beyond ASA class 
- Frailty identified by a multi-dimensional approach such as CGA was a much better 
predictor of short-term surgical outcomes than frailty identified through clusters of 
physical impairment (Fried frailty) 
- Frail older patients with colorectal cancer have higher pre-operative levels of the 
inflammatory markers CRP and IL-6 than non-frail patients 
- IL-6 was an independent predictor of post-operative complications when adjusting for 
tumor location and frailty status 
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Suggestions for further research 
There are a number of issues that should be further explored. Firstly, studying the impact of 
colorectal cancer surgery on functional, cognitive, and emotional status, general health, and 
quality of life will be very interesting. Medical student Benedicte Rønning has collected such 
data, and we are eagerly awaiting the results of the analyses of her data obtained from home 
visits to many of our patients. Secondly, given that frail patients experienced significantly 
more post-operative complications, it would be interesting to randomize frail, elderly patients 
to interventions based on a CGA versus usual care, and to see if this approach can decrease 
the rate of complications. Our research group is about to launch a randomized controlled 
study in frail elderly patients scheduled for elective surgery for colorectal cancer to test this 
hypothesis. Ideally, this approach should have been integrated with establishing ERAS in the 
hospitals, but unfortunately this does not seem to be in place to date. 
 
Further research on the role of comorbidity and functional status in relation to surgical 
outcomes in elderly patients is needed. In addition, it would be interesting to expand on the 
knowledge of how the occurrence of post-operative complications influences long-term 
survival. It has been suggested that the occurrence of post-operative complications reduces 
long-term survival independently of pre-operative patient factors137, but an alternative 
explanation is that data regarding patient factors were not extensive enough. 
 
Interesting data have been published regarding cancer survivorship in elderly patients, and 
further research on this topic is also likely to improve decision-making, treatment planning, 
and information to patients.  
 
I would also like to see publications regarding how cancer treatment is delivered to elderly 
patients in Norway, for example by analyzing registry data.  
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ABSTRACT 
Objectives: To compare a pre-operative multi-domain frailty measurement based on 
a comprehensive geriatric assessment (CGA) to a modified version of the physical 
phenotype of frailty (PF) in a cohort of older adults with colorectal cancer, and to 
analyze the ability of the two measurements to predict post-operative complications 
and survival. 
Design: Prospective longitudinal study. 
Setting: Three university hospitals in Norway. 
Participants: Patients aged 70 or older electively operated for colorectal cancer. 
Measurements: A pre-operative CGA, self-reported quality of life, and 
measurements of grip strength and gait speed were performed. CGA-frailty was 
defined as fulfilling one or more of the following criteria: Dependency in activities of 
daily living, severe comorbidity, cognitive dysfunction, depression, malnutrition, or > 
seven daily medications. PF was defined as the presence of three or more of the 
following criteria: Unintentional weight loss, exhaustion, low physical activity, 
impaired grip strength, or slow gait speed. Outcome measures were post-operative 
complications and survival. 
Results: One hundred seventy-six patients (median age 80, range 70-94) were 
included. The agreement between the classifications was poor. CGA-frailty was 
identified in 75 (43%) patients, while PF was identified in 22 (13%) patients. Only 
CGA-frailty predicted post-operative complications [P= .001]. Both CGA-frailty and 
PF predicted survival.    
 
Conclusion: A multi-domain frailty measurement based on a CGA appears to be 
more useful than frailty identified from a modified version of the physical phenotype 
of frailty criteria in predicting post-operative complications in older adults operated for 
colorectal cancer. For long-term outcomes such as overall survival, both 
measurements are predictive. 
 
Key words: frailty, geriatric assessment, geriatric oncology, colorectal surgery, pre-
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INTRODUCTION 
Remaining life expectancy and treatment tolerance are important elements to 
consider when making treatment decisions in elderly cancer patients. Data from 
epidemiological studies, clinical trials, and studies of the biology of aging support the 
view that chronological age is not the most important factor in predicting remaining 
life expectancy and treatment tolerance.1-3 Examples of more useful predictors are 
functional status, comorbidity, and frailty. The term frailty is widely used in the 
medical literature, and describes “an elderly patient who is at heightened 
vulnerability to adverse health status change because of a multisystem reduction in 
reserve capacity”.4 Thus, identifying frailty in cancer patients is important because an 
increased risk of complications from anti-tumor treatment such as surgery and 
chemotherapy is very likely. How to recognize frailty, however, remains 
controversial.  
Within geriatric oncology, a widely used definition of frailty is derived from criteria first 
described by Winograd and later modified by Balducci.5,6 Based on a comprehensive 
geriatric assessment (CGA), a patient is categorized as frail according to this 
definition when fulfilling any of the following criteria: dependency in activities of daily 
living (ADL), three or more comorbid illnesses, the presence of geriatric syndromes 
(for example dementia, malnutrition, depression, delirium, and falls), or age > 85 
years. In this multi-component phenotype of frailty, deficits across different health 
domains, such as clinical, psychological, and functional, are considered to be 
predictors of treatment tolerance and life expectancy. This classification is 
comparable to an approach that was used by Jones and colleagues, where a frailty 
index was constructed from a CGA.7 Studies of colorectal surgery have identified 
single elements from a geriatric assessment, such as functional dependency,8 
 
comorbidity,9 weight loss10 and depression,11 as independent predictors of post-
operative morbidity. However, only a few surgical studies have performed a 
comprehensive geriatric assessment pre-operatively.12 In a study of older adults who 
underwent elective surgery for colorectal cancer, we found that frailty identified from 
a CGA, but not increasing age or American Society of Anesthesiologists (ASA) 
classification, predicted post-operative complications within 30 days of surgery.13  
Within the geriatric and biogerontological literature, a widely accepted definition of 
frailty is based on data from more than 5000 community dwelling individuals aged 65 
years and older who participated in the Cardiovascular Health Study.14 The physical 
phenotype of frailty based on data from this study was defined as fulfilling at least 
three of the following five criteria: unintentional weight loss, exhaustion, slow walking 
speed, low physical activity, and weakness. This approach does not include 
comorbidity and cognition, but highlights the association of frailty with physiological 
and metabolic changes leading to a loss of functional capacity. A physiologic loss of 
reserves is identified through clusters of physical impairments. The physical 
phenotype of frailty predicts incident falls, hospitalizations, worsening mobility, and 
deaths in large cohorts.14,15 It has to our knowledge not been tested whether this 
physical phenotype of frailty is able to predict short-term outcomes, such as post-
operative complications after elective surgery, in a homogeneous cohort of elderly 
patients.  
Thus, the aim of this prospective longitudinal study was to compare a multi-domain 
frailty classification based on CGA to a frailty classification based on a modified 
version of the physical frailty phenotype in a cohort of older adults with stage I to IV 
colorectal cancer who underwent elective colorectal surgery. By comparing the 
ability of the two classifications to predict post-operative complications and overall 
 
survival, we may get an indication of the most useful approach to identifying 
susceptible elderly patients at risk for surgical morbidity.  
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METHODS 
Setting and patients 
The eligibility criteria for this study included: age 70 years or older, being scheduled 
for surgery of a suspected or confirmed colorectal cancer in three Norwegian 
hospitals from November 2006 through June 2008, and ability to provide a written 
informed consent. The Regional Committee for Medical and Health Research Ethics 
in East Norway approved the study. The principal investigator, a medical doctor with 
training in geriatrics, performed the pre-operative assessments 0 to 14 days prior to 
surgery at the hospitals. 
CGA measurements and CGA-classification 
Functional dependence in ADL and instrumental ADL (IADL) were assessed using 
the Barthel Index (BI) and the Nottingham Extended Activities of Daily Living Scale 
(NEADL).16,17 Comorbidity was registered from hospital records, supplied with 
information from the patient interview, and scored by using the revised Cumulative 
Illness Rating Scale (CIRS) manual from 2008.18,19 The CIRS assesses fourteen 
organ systems, and comorbidity in each organ system is scored on a five-point scale 
ranging from grade 0 (no problem) to grade 4 (extremely severe/immediate 
treatment required/end organ failure/severely impaired function). The Mini Nutritional 
Assessment (MNA), Mini Mental State Examination (MMSE) and the Geriatric 
Depression Scale (GDS), were used to assess nutritional, cognitive, and emotional 
status, respectively.20-22 The number of systemic drugs in daily use was recorded 
from the hospital records. A previous publication provides more detailed descriptions 
of the tools used in the CGA assessment and the reasoning behind the selected cut-
off values.13  
 

Based on the pre-operative CGA assessment, patients were categorized into the 
three groups "fit", "intermediate" and "frail" using a modification of the criteria 
proposed by Balducci and Extermann.6,23 CGA-frailty was defined as fulfilling one or 
more of the following criteria: Dependency in activities of daily living, severe 
comorbidity, cognitive dysfunction, depression, malnutrition, or > seven daily 
medications. According to the Balducci-categorization, patients who require 
assistance with ADL are classified as frail, while independence in both ADL and 
IADL is required for placement in the fit category. During recent years, cut-off scores 
for comorbidity and cognition using CIRS and MMSE have been established in the 
geriatric oncology literature.24,25 Comorbidity was classified in the following way: 
mild/no comorbidity when there was no comorbidity higher than grade 2 and less 
than three grade 2 comorbidities, moderate comorbidity when there were a 
maximum of two grade 3 comorbidities and no grade 4 comorbidity, or severe 
comorbidity when there were three grade 3 comorbidities or any grade 4 comorbidity. 
Cognitive dysfunction was defined as an MMSE score of 0-23, while cognition was 
categorized as normal when the score was 27-30. Due to the lack of a standardized 
definition of geriatric syndromes, we omitted this term as a frailty criterion. Instead 
we used the scoring from MNA (nutrition) and GDS (depression) and used cut-off 
criteria proposed by the authors of these tools to categorize the patients.21,22 
Furthermore, we removed age > 85 years as a classification criterion for frailty. To 
our knowledge, there is no agreed definition on how to categorize polypharmacy in 
the context of frailty. Even though the use of five or more prescription drugs is 
commonly referred to as polypharmacy,26 the prevalence of such drug use was 
reported to be 39% in a Swedish study of individuals 65 years or older.27 We chose a 
number slightly higher than five in order to identify patients who were likely to have 
 
severe comorbidity. A comparison of frailty-defining criteria in the two categorizations 
is presented in Table 1. 
Frailty indicators used to operationalize the physical frailty phenotype14 
In order to classify the patients according to the physical frailty phenotype, we used 
information from the CGA assessment, self-reported quality of life, and physical 
measurements. Information about weight loss was obtained from MNA; and a loss of 
greater than 3 kg during the last three months was considered a positive weight loss 
criterion. Maximal grip strength was measured on the dominant side with a handheld 
Jamar dynamometer, and the same cut-offs as described by Fried et al according to 
gender and body mass index were used.14 Subjective exhaustion was based on self-
report from the European Organization for the Research and Treatment of Cancer 
Quality of Life Questionnaire C30 (EORTC QLQ-C30), a widely used oncology tool 
measuring self-reported health during the last week.28 When a patient answered 
either “quite a bit” (score 3) or “very much” (score 4) on either question 12 (“Have 
you felt weak?”) or question 18 (“Were you tired?”), the exhaustion criterion was 
considered positive. Slowness was defined as a time of ≥ 19 seconds on the timed 
up and go (TUG) test. This cut-off was derived from the TUG time distributions in the 
Canadian Study of Health and Aging (CSHA). CSHA is one of the largest population-
based studies to include the TUG.29 In the original physical frailty phenotype 
definition, slowness was defined as the slowest 20% of the population walking 15 
feet. A cutoff of 19 seconds approximately identifies the slowest quintile among the 
non-institutionalized participants in the CSHA. Low physical activity was 
operationalized as scoring 3 or 4 on question 4 from EORTC QLQ-C30 (“Do you 
need to stay in bed or a chair during the day?”). Frailty was defined as fulfilling three 
or more of these five criteria, while patients fulfilling one or two were considered pre-
 
frail. Those with no characteristics were considered robust. As in the original paper 
by Fried and colleagues, patients considered evaluable for frailty had three or more 
non-missing frailty components.14 Table 2 compares the criteria used to 
operationalize the physical frailty phenotype to the original phenotypic criteria. 
Post-operative measurements 
Complications were broadly defined as any event occurring within 30 days of surgery 
requiring treatment measures that are not routinely applied post-operatively for 
colorectal cancer. In order to present the morbidity data in a standardized and 
reproducible manner we classified complications as minor (grade I), potentially life-
threatening without (grade II) or with (grade III) lasting disability, or fatal (grade IV) 
based on the morbidity grading system developed by Clavien et al.30 For example, a 
lower urinary tract infection was classified as a grade I complication, while 
pneumonia was a grade II complication. This classification of post-operative 
complications has been used in other studies of gastrointestinal surgery in the 
elderly,31,32 and allows for separate outcome variables according to the severity of 
morbidity. The following complementary approach was used to ensure a 
comprehensive collection of morbidity data: data were extracted from all available 
medical records; including charts, doctor’s notes (inpatient and outpatient), nurses’ 
notes, and discharge papers. In uncertain cases the medical team, nursing homes, 
caregivers, or patients were consulted in order to ensure a complete 30-day 
recording of complications. The final scoring of complications according to the 
Clavien classification30 was subsequently done in collaboration with a colorectal 
surgeon. Post-operative mortality was defined as death within 30 days after surgery.  
 
Information on patients’ deaths was retrieved from the National Registry of Norway. 
All deaths identified as of August 10, 2009 were included in the current analysis. 
Statistical analyses 
For the frailty categorizations, the degrees of agreement between the two measures 
were tested with the Kappa Measure of Agreement.  
Two dichotomized outcome variables were created for 30-day post-operative 
morbidity: “severe” complications (grade II or higher according to the classification by 
Clavien et al.30) versus “no/mild” complication, and “any” complication versus “no” 
complication. Chi-square tests for trend were used to compare the associations 
between these outcomes and the potentially predictive factors CGA-classification (fit, 
intermediate, or frail) and modified physical frailty phenotype (robust, pre-frail, or 
frail). In addition, bivariate associations between the dichotomized physical frailty 
indicators weight loss, weakness, exhaustion, slowness, and low activity and the 
outcome severe complications were assessed using chi-square tests. Physical frailty 
indicators with a p-value less than 0.10 were entered into a multivariable logistic 
regression model with elements from the CGA that have previously been identified 
as bivariately associated with the outcome severe complications.33 Rectal cancer 
was a strong independent predictor of severe post-operative complications in this 
dataset, and tumor location was therefore included in the multivariable model.13 
Independent predictors of severe complications were then identified through a 
backward stepwise logistic regression analysis. 
Survival curves were estimated by the Kaplan-Meier method and compared by the 
log rank test. Overall survival was compared between age groups (70-79 years 
compared to 80-94 years), according to cancer stage (grouped into stages 0-II, III, 
 
and IV), according to CGA-classification (fit, intermediate, or frail), and according to 
the modified Fried phenotype (robust, pre-frail, or frail). Cancer stage was entered 
into a Cox proportional hazards model with CGA-classification and the modified 
Fried phenotype, respectively. As the proportionality assumption was not fulfilled for 
the CGA-classification, this variable was dichotomized into frail versus non-frail. 
All statistical analyses were performed using SPSS 15.0 software (Chicago, IL).  
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RESULTS 
Of the 187 patients included pre-operatively, 176 were evaluable for frailty according 
to both CGA-classification and the modified physical phenotype of frailty. Age ranged 
from 70 to 94 years, with a mean and median age of 80 years, and there were 101 
(57%) women. A total of 171 (97%) patients lived in their own home, and 84 (48%) 
lived alone. Of the 92 patients who did not live alone, 87 (95%) lived with their 
spouse. Thirty-six patients (21%) had public help, while 46 (26%) received help from 
relatives or friends on a regular basis. The cancer was localized to colon in 125 
(71%) patients, while the remainder had rectal cancer. A total of 21 (12%) patients 
had metastatic disease. 
Based on CGA, the number of patients categorized as fit, intermediate, and frail was 
21 (12%), 80 (45%), and 75 (43%), respectively. According to the modified physical 
phenotype of frailty, 70 (40%) were robust, 84 (48%) were pre-frail, and 22 (13%) 
were frail. As seen in Table 3, the two measurements selected different patients as 
frail, and the Kappa Measure of Agreement value was 0.05, representing poor 
agreement. Of the 75 patients classified as frail according to the CGA, only 17 were 
frail according to the physical phenotype of frailty. Of the 101 patients classified as 
non-frail according to the CGA, 96 were classified as non-frail according to the 
physical phenotype of frailty. When comparing the relationships between the two 
frailty classifications and the occurrence of post-operative complications, we found 
that frailty defined from CGA significantly predicted any post-operative complication 
(p=0.001) as well as severe complications (p=0.002). The most common severe 
complications in the frail group were pulmonary complications in 18 patients (24%), 
cardiac complications in 17 patients (23%), and delirium in 10 patients (13%). The 
 
most common severe complications in the patients who were not frail according to 
the CGA were wound infection requiring systemic antibiotics in 13 patients (13%), 
pulmonary complications in 8 patients (8%), and cardiac complications in 8 patients 
(8%). Anastomotic leakage was observed in 7 patients who were frail according to 
CGA, compared to 2 patients who were not frail according to CGA (relative risk 5.1, 
95% confidence interval 1.03 to 25.28). Increasing frailty identified from the modified 
physical frailty phenotype was neither a significant predictor of any complication 
(p=0.18) nor of severe complications (p=0.23). Of the five physical frailty indicators, 
only low activity was associated with the outcome severe complications (p=0.10). 
When this indicator was included in a multivariable model with the elements of CGA 
that were bivariately associated with severe post-operative complications (IADL, co-
morbidity, and nutritional status), low activity was the first variable to be removed 
from the risk prediction model at a p-level of 0.21.  
There were no differences in morbidity according to cancer stage in this cohort. 
Three patients (1%) died within 30 days of surgery.  
Overall, the median follow-up time was 20 months (interquartile range, 15 to 25). 
Both frailty classifications were associated with overall survival, and the results are 
displayed in Table 4.  
When correcting for cancer stage in the Cox regression model, frailty classified by 
CGA remained an independent predictor of mortality. When correcting for cancer 
stage in the Cox regression model of the modified physical frailty phenotype, both 
pre-frailty and frailty were significant predictors of survival. The results are displayed 
in Table 5. 
 
 
DISCUSSION 
This study of older adults with colorectal cancer demonstrated poor agreement 
between two different ways of identifying frailty – one based on geriatric assessment 
criteria and the other based on a modified version of the physical phenotype of frailty 
criteria. The two classifications were quite consistent in terms of the cases classified 
as non-frail; however, there was inconsistency between the cases each method 
considered frail. Interestingly, only one of the frailty classifications was able to predict 
post-operative complications. The use of a frailty measure as a result of CGA was a 
much better predictor of 30-day morbidity than the modified physical frailty 
phenotype. The frailty identified by the physical frailty phenotype was neither a 
significant predictor of any post-operative complication nor of the severity of 
complications, whereas the CGA-based frailty measure predicted post-operative 
complications as well as severe complications. Both frailty classifications were 
predictive of overall survival. 
Frailty is defined by a limited reserve capacity and a heightened vulnerability to 
adverse events. Thus, aggressive treatment modalities may expose a frail patient to 
complications and toxicity. Identifying frailty before treatment is initiated may identify 
patients who would benefit from targeted interventions aimed at improving the 
patient’s tolerance to therapy, or identify patients where the risk versus benefit ratio 
of therapy is too high. The physical phenotype of frailty does not readily identify 
remediable conditions that may be optimized pre-operatively, such as comorbidity 
and polypharmacy, and did not provide pre-operative risk information in our study, as 
opposed to the CGA-classification. We have previously identified that comorbidity, 
IADL-dependency, and depression are CGA-elements that independently predict 
 
post-operative complications.33 The one-dimensional physical frailty phenotype does 
not include comorbidity or psychological factors, and this appears to limit its 
usefulness in the pre-operative setting. Our results are difficult to compare to 
previous studies, as we are not aware of other studies that have examined the 
predictive ability of these frailty measures for the same outcomes. A recent 
publication found that the criteria used in the physical phenotype of frailty predicted 
post-operative complications in a heterogeneous cohort of elderly surgical patients, 
but the standardized definition of the physical phenotype of frailty was not used in 
the study: intermediate frailty was defined as fulfilling 2-3 of the five criteria, while 
frailty was defined as fulfilling 4-5 criteria.34 Thus, the results cannot be directly 
compared to our results. 
The discrepancy between the two definitions warrants further discussion. Firstly, the 
prevalence of CGA-frailty is much higher than the prevalence of frailty identified by 
the modified physical phenotype. CGA-frailty is conceptually more closely related to 
frailty measured by deficit accumulation,29 and estimates of frailty based on deficit 
accumulation were higher than estimates based on the phenotypic definition of frailty 
in the population-based United States Health and Retirements Study.35 To our 
knowledge, the prevalence of two such measurements has not been compared in a 
hospital-based elderly cohort similar to ours. One explanation for the discrepancy 
may be that severe comorbidity was by far the most frequently appearing CGA-frailty 
defining criterion in our cohort,13 while comorbidity is not part of the physical 
phenotype of frailty.   
The physiologic loss of reserves is a key component of frailty, and it is inherent in the 
concept that a frail elderly person is less able to integrate an adequate stress 
response. A bowel resection may be viewed as stress test of a patients’ ability to 
 	
compensate the surgical trauma, and the occurrence of post-operative complications 
may to some extent be an indirect measure of loss of functional reserves. However, 
morbidity is also influenced by several other factors, for example extent of surgery, 
type of anesthesia, and surgical skills. Even though only the CGA-based frailty 
measure in our study was associated with morbidity, both frailty measures predicted 
overall survival, and one can argue that poor survival is also an indication of loss of 
functional reserves.  
A morbidity rate of 60% under elective conditions is higher than reported in most 
colorectal series; estimates from 20% to 30% being more common.9 However, a 
morbidity rate similar to ours was reported in a recent publication by Audisio et al.12 
Morbidity rates are difficult to compare due to differences in methods of data 
collection as well as in ways of classifying complications. It has been shown that the 
estimated rate of wound infections increases by 53-99% when reported by 30-day 
complete outpatient and inpatient reporting.36,37 Furthermore, post-operative delirium 
is often not reported in the surgical literature, despite being a common and serious 
complication in elderly surgical patients. In our study, two methodological factors 
may have contributed to the high rate of complications. Firstly, all events requiring 
treatment measures not routinely applied post-operatively were considered to be 
post-operative complications. Secondly, several complementary methods were used 
in order to ensure a thorough recording of morbidity data, as described in the 
methods section. 
The Cox regression analysis demonstrated that cancer stage and frailty (according 
to both classifications) were independent predictors of mortality after a median 
follow-up time of 20 months. Interestingly, increasing age actually resulted in a (non-
significant) reduced hazard ratio for mortality. As increasing age was neither a 
 

predictor of post-operative morbidity nor of overall survival in our cohort, it appears 
that selected octa- and nonagenarians tolerate colorectal cancer surgery well, and 
should be offered treatment when colorectal cancer impacts on remaining life 
expectancy or in the likelihood of local tumor complications.  
A limitation of our study is that phenotypic frailty was not measured in the exact 
same way as in the original publication.14 Furthermore, our hospital-based cohort 
consists of elderly patients who underwent surgery for cancer, while Fried and 
colleagues included subjects from the general population and excluded patients with 
active cancer from the CHS study. Even though the resection rate is high even in 
advanced age in colorectal cancer,38 our patients have already been selected 
through primary care and the pre-operative surgical evaluation, and are not 
representative of the general population. In addition, our cohort is considerably older 
than the CHS-cohort where 67% of the patients were aged 65-74 years. In contrast, 
75% of our cohort was 75 years and older. This may explain the higher prevalence of 
physical frailty in our study (13% versus 7%). A limitation regarding CGA-frailty is 
that the cut-off criterion for polypharmacy is not well defined in the literature. 
Furthermore, MMSE scores were not adjusted for level of education. Another 
limitation of our analysis is that we have not addressed important endpoints such as 
physical functioning after surgery. In addition, data regarding post-operative 
complications were recorded retrospectively, and this is a weakness of the study. 
However, as described above, we used several complementary approaches to 
ensure a comprehensive recording of morbidity data. Our results need validation in a 
separate cohort. 
An important strength of our dataset is that the cohort is truly elderly, with a median 
age of 80 years. Furthermore, all these patients have the same index disease, and 
 
they were thoroughly examined before a relatively standardized major procedure – 
an elective bowel resection. This allowed us to compare two widely used frailty 
measurements in a homogeneous cohort. It is still unclear whether identifying frailty 
may contribute to the decision-making in geriatric medicine, and data regarding the 
predictive validity of frailty for complications of treatment and survival are lacking.   
Successful surgical care of elderly cancer patients depends on several factors, such 
as pre-operative patient selection, avoiding emergency surgery, and careful peri-
operative handling of patients. Growing evidence indicates that post-operative 
complications, in addition to decreasing well being of patients and increasing the risk 
of post-operative mortality, also may have important effects on long-term survival 
and recovery to pre-operative levels of independence.39-41 According to our findings, 
a pre-operative CGA may identify elderly patients with a high risk of post-operative 
complications. Elements from a CGA are superior to measurements of chronological 
age and ASA-class,13 as well as objective functional measurements such as gait 
speed and grip strength. Particularly relevant CGA-elements in this dataset were 
severe comorbidity, as measured by CIRS, IADL-dependency, and depression.33 
Comorbidity may be optimized, depression can be treated, and IADL can be 
supported. A prospective randomized trial of susceptible elderly surgical patients 
would yield information about whether geriatric assessment and targeted intervention 
can improve surgical oncology care by decreasing the rate of post-operative 
complications. 
In conclusion, the optimal tool to measure frailty will vary according to the specific 
outcome in question. For planning health care services on a population level, 
identifying risk of mortality and worsening mobility through a quick assessment such 
as the physical frailty phenotype is suitable. This classification has been validated in 
 
several population-based studies as identifying those at high risk for disability, falls, 
hospitalizations, hip fracture, and mortality.42-45 For prediction of treatment tolerance, 
such as post-operative complications, our results indicate that a multi-component 
classification of frailty based on geriatric assessment criteria is more useful. 
Furthermore, CGA may unmask remediable problems, and consequently allow for 
pre-treatment patient optimization. Future studies are needed to test the ability of 
CGA-guided interventions to decrease surgical morbidity. 
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Table 2. Frailty-defining Criteria Adapted From the Criteria Based on the Cardiovascular Health Study (Fried criteria) 
14 
Characteristic Fried criteria Criteria used in current study 
Weight loss Lost > 10 lbs unintentionally in last y Weight loss greater than 3 kg during the last 3 months 
(question B from MNA) 
Weakness Grip strength: lowest 20% (by gender, BMI) Same as in Fried criteria 
Exhaustion Self-report of either: 
• Feeling everything I did was an effort in the 
last wk 
• Could not get going in the last wk 
Score 3 (“quite a bit”) or 4 (“very much”) on either 
question 12 (“Have you felt weak?”) or 18 (“Were you 
tired?”) from EORTC QLQ-C30 
Slowness Walking 4.57 m: 
• Time ≥ 7 s for height < 160 cm 
• Time ≥ 6 s for height > 159 cm 
TUG ≥ 19 seconds 
29
  
Low activity MLTA questionnaire (short version) 
• Evaluating all 18 items 
• < 270 kcals per wk on activity scale 
Score 3 or 4 on question 4 (“Do you need to stay in 
bed or a chair during the day?”) from EORTC QLQ-
C30 
Overall frailty 
status 
Robust: 0 criteria 
Pre-frail: 1 or 2 criteria 
Frail: 3 or more criteria 
Same as in Fried criteria 
Abbreviations: MNA, mini nutritional assessment; BMI, body mass index; EORTC QLQ-C30, European Organization for the 
Research and Treatment of Cancer quality of life questionnaire C30; TUG, timed up and go; MLTA, Minnesota Leisure Time 
Activity; kcals, kilocalories. 
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Table 3. Comparison of Frailty-defining Criteria and Relations to Severe Post-operative 
Complications 
Modified physical phenotype of frailty  
CGA-classification Robust Pre-frail Frail 
 
 
Total 
 
No. severe 
morbidity (%) 
Fit 12 9 0 21 7 (33) 
Intermediate 42 33 5 80 29 (39) 
Frail 16 42 17 75 46 (61) 
Total / no. severe 
morbidity (%) 
70 / 28 (40) 84 / 43 (51) 22 / 11 (50) 176 82 (47) 
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Table 5. Frailty-classifications as Predictors of Mortality by Cox Regression Analyses. The Final 
Models Are Corrected for Cancer Stage and Age. 
Variables Hazard Ratio 95% CI P 
Model with CGA-frailty    
   Cancer stage 
      TNM 0, I, and II 
      TNM III 
      TNM IV 
 
1.00 
3.14 
10.62 
 
 
1.51 - 6.53 
  5.04 - 22.37 
 
 
.002 
< .001 
   Age    
      70-79 1.00   
      80-94 0.74   0.41 - 1.34 .32 
   CGA-classification 
      Non-frail 
      Frail 
 
1.00 
3.39 
 
 
 1.82 - 6.29 
 
 
< .001 
Model with modified Fried phenotype    
   Cancer stage 
      TNM 0, I, and II 
      TNM III 
      TNM IV 
 
1.00 
2.77 
11.87 
 
 
1.30 - 5.90 
  5.52 - 23.74 
 
 
.008 
< .001 
   Age    
     70-79 1.00   
     80-94 0.78   0.43 - 1.41 .40 
   Modified Fried phenotype 
      Robust 
      Pre-frail 
      Frail 
 
1.00 
2.33 
2.67 
 
 
1.16 - 4.67 
1.11 - 6.83 
 
 
.018 
.029 
Abbreviations: CI, confidence interval; CGA, comprehensive geriatric assessment. 

IV

SUPPLEMENTARY DATA 
Appendix 1 
CGA assessment tools and frailty classifications. 
Functional dependence was assessed by the Barthel Index and the Nottingham Extended 
Activities of Daily Living Scale, (NEADL) [1,2]. To evaluate comorbidity and nutritional status, 
the Cumulative Illness Rating Scale (CIRS) and the Mini Nutritional Assessment (MNA) were 
used [3,4]. Depression and cognitive function were measured by the Geriatric Depression 
Scale (GDS) and the Mini Mental State Examination (MMSE), respectively [5,6].  
Objective measures of physical function were the timed up-and-go test (TUG) and grip 
strength. TUG measures time needed to get up from a chair, walk three meters, turn, walk 
back and sit down again [7]. Dominant side grip strength was measured using a Jamar® 
handheld dynamometer.  
Finally, patients completed the European Organization for the Research and Treatment of 
Cancer Quality of Life Questionnaire C30 (EORTC QLQ-C30). This validated questionnaire 
includes questions regarding physical, cognitive, emotional, social and role functioning, as 
well as symptoms. Questions are answered on a four-point scale ranging from “not at all”, “a 
little”, “quite a bit” to “very much”. In addition, patients are asked to grade their overall health 
status and quality of life on a numeric scale from one to seven [8]. 
Patients were classified as frail according to the CGA if they had either severe comorbidity or 
used more than seven medications daily, were functionally dependent in personal activities 
of daily living, were malnourished, had reduced cognitive function or depression. To be fit, 
patients had to fulfil all of the following criteria: mild or no comorbidity, less than four daily 
medications, functional independence, normal nutritional status, normal cognitive function 
and no depression. Patients were classified as intermediate if they had no frailty-criteria, but 
did not fulfil all fit-criteria. For cut-off criteria, see table A, Appendix 2.  
Data from the CGA were used to create an approximation to the Fried frailty phenotype. To 
fulfil the weight loss criterion, patients had to have lost > 3 kg over the past three months. 
Reduced walking speed was defined as using >19 seconds to complete the TUG-test [9]. 
For the muscle weakness criterion, grip strength cut-off values from the original paper by 
Fried et al. were used [10]. Self-reported exhaustion was defined as answering “quite a bit” 
or “very much” to either one of the questions: “Have you felt weak” or “Were you tired”, from 
the EORTC QLQ-C30. Low physical activity was defined as giving one of the same answers 
to the question “Do you need to stay in bed or a chair during the day?” from this 
questionnaire. Patients fulfilling three or more criteria were considered frail; those with one or 
two criteria were pre-frail and patients not fulfilling any criteria were robust. The presence of 
assessment data in at least three domains was required to be eligible for classification 
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Appendix 2 
Table A 
CGA-classification criteria. 
 Fit – all of the following 
criteria  
Frail – one or more of 
the following criteria 
Intermediate  
CIRS No > grade 2 comorbidity 
+ < 3 grade 3 
comorbidities 
>1 grade 4 comorbidity / 
> 2 grade 3 
comorbidities 
Polypharmacy < 5 daily medications >7 daily medications 
Barthel Index >18 <19 
NEADL >43  
MMSE >26 <24 
Patients who 
neither fulfilled the 
criteria for being fit, 
nor frail, were 
classified as 
intermediate.  
MNA >23.5 <17  
GDS  >13  
 
CGA = Comprehensive Geriatric Assessment 
CIRS = Cumulative Illness Rating Scale 
NEADL = Nottingham Extended Activities of Daily Living 
MMSE = Mini Mental State Examination 
MNA = Mini Nutritional Assessment 
GDS = Geriatric Depression Scale 
 
Appendix 3 
Preoperative blood samples 
Blood samples were collected for routine preoperative testing and additional blood was 
drawn for serum preparation, by centrifugation according to guidelines at the individual 
hospital laboratories (3400-3700 rpm for 10-12 minutes). Serum was kept on ice during 
transport to be stored at -70° C.   
The D-dimer analyses were performed at the respective hospital laboratories, with the STA 
Liatest® D-Di (Diagnostica Stago, Asnières, France).  
CRP levels were determined in our laboratory using an enzyme linked immunosorbent assay 
(DRG Instruments GmbH, Germany), detection limit 0.1 mg/L, coefficient of variation (CV) 
<5%. The remaining biomarkers were measured using enzyme-linked immuno assays with 
commercially available kits (R&D Systems Europe, Abingdon, Oxon, UK): IL-6 (CV (in our 
lab) 10.5%) and TNF-a (CV 8,5%).  
 
Appendix 4 
Postoperative complications 
Postoperative complications were classified according to severity [1]. A grade I complication 
was a minor event that did not require treatment other than simple symptomatic drugs (for 
fever, pain or nausea). Simple urinary tract infection and urine retention were also included 
in this group. Another important criterion for a grade I complication was that it did not lead to 
a hospital stay “longer than twice the median stay for the procedure”.  
A grade II complication was a potentially life-threathening event, or an event that led to 
prolonged hospitalization beyond that of a grade I complication. A further subclassification 
was based on intervention characteristics; grade IIa required only medical therapy, 
parenteral nutrition or blood transfusion, whereas grade IIb could be resolved by invasive 
procedures.  
A grade III complication was also a potentially life-threatening event, further recognized by 
the development of lasting disability.  
Finally, a grade IV complication denoted the death of a patient due to a complication.  
The Clavien classification system was first developed for use in cholecystectomies, a goal 
being that it should be applicable to other types of surgical procedures. Because it is a highly 
comprehensive system, it is suitable for use in older patients, were even small events may 
lead to considerable discomfort. 
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Appendix 5 
Table B 
Patient characteristics (n=137) 
Median age, years (min-max) 80  (70-94) 
Sex 
% Male 
% Female 
 
62   (45%) 
75   (55%) 
 
Mean BMI, kg (SD) 24.6   (4.3) 
Tumour type: 
% Localized 
% Regional lymph node metastases 
% Distant metastases* 
% Not determined 
 
83    (61%) 
35    (25%) 
15    (11%) 
4      (3%) 
 
Tumour location 
% Colon 
% Rectum 
 
 
94   (69%) 
43   (31%) 
 
Physical frailty: 
% Robust 
% Pre-frail 
% Frail 
 
62  (45%) 
59  (43%) 
16  (12%) 
 
 
CGA-category: 
% Fit 
% Intermediate 
% Frail 
 
16   (12%) 
66   (48%) 
55   (40%) 
*Patients with distant metastases did not have significantly higher levels of biomarkers than 
those with localized disease, and were therefore included in the analyses. 
BMI= Body mass index 
SD= Standard deviation 
IQR= Interquartile range  
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